var title_f12_49_13072="Web space abscess";
var content_f12_49_13072=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F62829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F62829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Web space abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A web space abscess requires a combined palmar and dorsal approach for adequate drainage and debridement. Note that the incisions are not connected to each other.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13072=[""].join("\n");
var outline_f12_49_13072=null;
var title_f12_49_13073="Acemetacin: International drug information";
var content_f12_49_13073=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acemetacin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acemetacin Heumann (DE);",
"     </li>",
"     <li>",
"      Acemetacin intermuti (DE);",
"     </li>",
"     <li>",
"      Acemetacin Stada (DE);",
"     </li>",
"     <li>",
"      acemetacin von ct (DE);",
"     </li>",
"     <li>",
"      Acemix (IT);",
"     </li>",
"     <li>",
"      Acephlogont (DE);",
"     </li>",
"     <li>",
"      Altren (BE);",
"     </li>",
"     <li>",
"      Analgel (AR);",
"     </li>",
"     <li>",
"      Azeat (DE);",
"     </li>",
"     <li>",
"      Emflex (GB);",
"     </li>",
"     <li>",
"      Espledol (ES);",
"     </li>",
"     <li>",
"      Flamarion (AR);",
"     </li>",
"     <li>",
"      Gynalgia (AR);",
"     </li>",
"     <li>",
"      Mostanol (DE);",
"     </li>",
"     <li>",
"      Oldan (ES);",
"     </li>",
"     <li>",
"      Rantudil (DE, LU, MX, PT);",
"     </li>",
"     <li>",
"      Rheutrop (AT);",
"     </li>",
"     <li>",
"      Solart (IT);",
"     </li>",
"     <li>",
"      Tilur (CH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1977566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nonsteroidal Anti-inflammatory Drug (NSAID), Oral",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1977569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of rheumatoid arthritis, osteoarthritis, low back pain, and postoperative pain and inflammation",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1977565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: Initial: 120 mg/day in divided doses; may increase to 180 mg/day in divided doses, based on patient response",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1977568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Capsule: 60 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Capsule, extended release: 90 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10480 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FDEBE4EB0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13073=[""].join("\n");
var outline_f12_49_13073=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303299\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977566\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977569\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977565\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821103\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977568\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10480\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10480|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_49_13074="2D TTE parasternal short axis view aortic root";
var content_f12_49_13074=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 646px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) parasternal short axis view of the aortic root",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 626px; height: 173px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A diagram of the transducer position for obtaining a short axis two dimensional image; the short axis is obtained by a 70&deg; to 110&deg; clockwise rotation of the transducer from the parasternal long axis, with superior and inferior transducer manipulations and the plane is oriented at the base of the heart (left panel).",
"    <br>",
"     (B and C) The parasternal short axis view from a transthoracic echocardiogram shows the noncoronary (NCC), right coronary (RCC) and left coronary (LCC) leaflets of the aortic valve. Also seen are the left atrium (LA), right atrium (RA), tricuspid valve (TV), right ventricle (RV) and pulmonic valve (PV).",
"     <div class=\"footnotes\">",
"      <p>",
"       &nbsp;",
"      </p>",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13074=[""].join("\n");
var outline_f12_49_13074=null;
var title_f12_49_13075="Membranous VSD with LV to RA shunt still frame";
var content_f12_49_13075=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Membranous VSD with LV to RA shunt still frame",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 417px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subcostal coronal still frame with color flow mapping showing the LV-RA shunt. This communication is between the LVOT and the RA. The defect (arrow) directs blood into the RA directly from the LVOT, entering just above the septal leaflet of the tricuspid valve.",
"    <div class=\"footnotes\">",
"     LA: left atrium; RA: right atrium; LV: left ventricle; RV: right ventricle; IVS: intraventricular septum; LVOT: left ventricular outflow tract; TV: tricuspid valve; arrow: VSD.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13075=[""].join("\n");
var outline_f12_49_13075=null;
var title_f12_49_13076="Aortic regurgitation hemodynamics";
var content_f12_49_13076=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Aortic regurgitation hemodynamics",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aortic regurgitation. Note upsloping LV diastolic pressure and wide pulse pressure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13076=[""].join("\n");
var outline_f12_49_13076=null;
var title_f12_49_13077="Computerized tomography cecal volvulus";
var content_f12_49_13077=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 619px\">",
"   <div class=\"ttl\">",
"    Computerized tomography (CT) cecal volvulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 599px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The axial CT scan (A) shows an air contrast level trapped in the dilated cecum (arrow). In image B the counterclockwise \"whirl sign\" is evident (arrowhead).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13077=[""].join("\n");
var outline_f12_49_13077=null;
var title_f12_49_13078="Mesorectum - Male pelvis lateral view";
var content_f12_49_13078=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Mesorectum - Male pelvis lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 558px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the lateral view of the male pelvis,&nbsp;illustrating the relationship of the mesorectum to the posterior rectum and presacral space. The mesorectum is&nbsp; not a true mesentery, but rather is perirectal areolar tissue that is thicker posteriorly and contains terminal branches of the inferior mesenteric artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13078=[""].join("\n");
var outline_f12_49_13078=null;
var title_f12_49_13079="Alcoholic steatohepatitis - lower power";
var content_f12_49_13079=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alcoholic steatohepatitis (lower power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In addition to fat-filled hepatocytes, there are swollen necrotic hepatocytes and early scarring and inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13079=[""].join("\n");
var outline_f12_49_13079=null;
var title_f12_49_13080="Pathologic skin picking";
var content_f12_49_13080=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathologic skin picking",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Kelly KyungHwa Park, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13080/contributors\">",
"     John Koo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Erik Stratman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13080/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/49/13080/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H15211814\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic skin picking (PSP) is a disorder characterized by deliberate and repetitive manipulation of the skin, causing tissue damage. This topic will discuss the clinical features, evaluation, and management of the patient with PSP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44169844\">",
"    <span class=\"h1\">",
"     DEFINITION AND CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic skin picking is defined as repetitive picking, scratching, rubbing, digging, or squeezing of skin, resulting in visible tissue damage and impairment in social functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/1\">",
"     1",
"    </a>",
"    ]. Psychogenic excoriation, lichen simplex chronicus, neurodermatitis, neurotic excoriation, acne excori&eacute;e, and dermatillomania (dermatotillomania) are synonyms of PSP.",
"   </p>",
"   <p>",
"    Although there is no formal set of diagnostic criteria for PSP in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR",
"    <sup>",
"     &reg;",
"    </sup>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/2\">",
"     2",
"    </a>",
"    ], the disorder is included in the group of the impulse control disorders not elsewhere classified, along with trichotillomania [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/2\">",
"     2",
"    </a>",
"    ]. However, some patients with PSP may present with characteristics of obsessive-compulsive disorder.",
"   </p>",
"   <p>",
"    The essential feature of impulse control disorders is the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the person or to others. For most of the these disorders, the individual feels an increasing sense of tension or arousal before committing the act and then experiences pleasure, gratification, or relief at the time of committing the act. Following the act there may or may not be regret, self-reproach, or guilt [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By contrast, in obsessive-compulsive disorder, compulsions are repetitive, intentional behaviors performed in a stereotyped manner in an attempt to alleviate or neutralize anxiety or distress that is caused by obsessions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=see_link&amp;anchor=H4#H4\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Clinical manifestations and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211823\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of PSP in the general population is unknown. In a telephone survey, 1.6 percent of a random sample of 2511 adults residing in the United States reported skin picking with noticeable skin damage [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/3\">",
"     3",
"    </a>",
"    ]. These individuals also reported distress and psychosocial impact associated with skin picking. In another United States population-based study, 5.4 percent of 354 participants reported PSP and associated impairment in daily functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/4\">",
"     4",
"    </a>",
"    ]. In two samples of college students, the prevalence of severe, self-injurious skin picking was 3.8 and 4.6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. PSP was usually triggered by cutaneous stimuli or specific emotional situations. Skin picking accounts for about 2 percent of all visits to the dermatology clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The age of onset of PSP spans between 15 and 45 years, with a peak noted in the early twenties [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ]. The duration of illness ranges from 5 to 21 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Childhood onset may progress into adulthood in up to 47 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ]. Individuals with childhood-onset disease share similar characteristics with those with late-onset disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/1\">",
"     1",
"    </a>",
"    ]. However, childhood onset is associated with longer disease duration and less motivation for treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PSP is most common in women, with a female to male ratio of about 8:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/3,4,10,11\">",
"     3,4,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211830\">",
"    <span class=\"h1\">",
"     COMORBID CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple psychiatric comorbidities are associated with PSP. These include major psychiatric disorders as well as associated behaviors such as trichotillomania and onychophagia. In several studies, the following conditions were associated with PSP, with higher prevalences reported among patients attending psychiatric outpatient facilities [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/10,12-14\">",
"     10,12-14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Concurrent DSM-IV-TR Axis I disorder (major mental disorders and learning disorders), including depression, bipolar disorder,",
"      <span class=\"nowrap\">",
"       attention-deficit/hyperactivity",
"      </span>",
"      disorder, and eating disorders: 38 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Depression: 42 percent",
"     </li>",
"     <li>",
"      Obsessive-compulsive disorder: 15 to 68 percent",
"     </li>",
"     <li>",
"      Alcohol",
"      <span class=\"nowrap\">",
"       abuse/dependence:",
"      </span>",
"      40 percent",
"     </li>",
"     <li>",
"      Body dysmorphic disorder: 12 to 32 percent",
"     </li>",
"     <li>",
"      Trichotillomania 5 to 37 percent",
"     </li>",
"     <li>",
"      Onychophagia: 27 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211837\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSP appears as excoriated, polymorphic lesions of varying size, with wide variation in extent and severity. All stages of evolution may be represented on a background of post-inflammatory hypo- or hyperpigmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Recently induced lesions appear as angular excoriations with a serosanguineous crust; older lesions may be crusted or appear as hypertrophic nodules or atrophic scars. The appearance also depends on the specific method of PSP. Instrumentation may be employed through the use of fingers or fingernails, teeth, tissues, scissors, tweezers, or pins, producing deeper lesions that extend into the dermis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ]. Complications of PSP include ulceration, infection, scarring, and disfigurement.",
"   </p>",
"   <p>",
"    Frequently targeted sites are the face (in particular the nose, forehead, cheeks, and chin), the scalp, cuticles, extensor aspects of the extremities, shoulders, back, perianal region, and the scrotal area [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ]. Lesions are usually symmetrically distributed within reach of the hands (",
"    <a class=\"graphic graphic_picture graphicRef60854 graphicRef72635 graphicRef53693 graphicRef61686 graphicRef66802 graphicRef55043 graphicRef82620 \" href=\"UTD.htm?42/40/43658\">",
"     picture 1A-G",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with PSP will usually acknowledge an urge to pick and gouge at their skin. Although there may be an initial reluctance to disclose self-damage, patients are generally willing to discuss the need to pick as a response to itch to relieve tension.",
"   </p>",
"   <p>",
"    Patients may begin with the urge to manipulate a trivial skin lesion such as an arthropod bite, acne lesion, scab, inflammatory lesion, wart, mole, or keratin plug [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6,17-19\">",
"     6,17-19",
"    </a>",
"    ]. Others may manipulate perfectly normal skin, or pick the skin as a response to a cutaneous sensation of pruritus, burning, or pain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A PSP episode typically lasts 6 to 10 minutes; however, it is not uncommon for patients to dedicate hours to the process on a daily basis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6,12\">",
"     6,12",
"    </a>",
"    ]. Activity peaks in the evening, between the hours of 8 pm and 12 am [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Situations correlated with PSP activity include looking in a mirror, speaking on the telephone, lying in bed, reading, watching television, waiting, and bathing [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients may give various explanations for their PSP. They may report anxiety or emotional distress until they are able to pick their skin, which relieves these feelings [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6,21\">",
"     6,21",
"    </a>",
"    ]. There are also a proportion of patients who report an attempt to improve the appearance of their skin, those that report that it is simply a common habit, and others who find the actions pleasurable [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44169867\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A set of diagnostic criteria for PSP has been proposed by one author as a guideline for recognition, categorization, and treatment of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/1\">",
"     1",
"    </a>",
"    ]. These criteria take into account the heterogeneity of patients with PSP, and help classify the disorder as impulsive, compulsive, or mixed type (",
"    <a class=\"graphic graphic_table graphicRef67010 \" href=\"UTD.htm?29/16/29964\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Diagnostic criteria for the diagnosis of PSP are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrent excoriation of the skin, resulting in noticeable tissue damage",
"     </li>",
"     <li>",
"      Preoccupation with skin excoriation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent impulses to pick the skin",
"     </li>",
"     <li>",
"      The preoccupation, impulses, and behavior associated with skin picking are time-consuming, cause marked distress, interfere with social functioning, and cause medical complications",
"     </li>",
"     <li>",
"      The picking cannot be accounted for by another medical or mental disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PSP has the features of impulse control disorder if:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Picking is associated with feelings of pleasure, relief or satisfaction",
"     </li>",
"     <li>",
"      Picking is performed automatically",
"     </li>",
"     <li>",
"      There is little insight into the senselessness or harmfulness of the behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PSP shares the characteristics of an obsessive-compulsive disorder when:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Picking is performed to avoid anxiety or prevent a dreaded event or situation, or is elicited by an obsession (eg, contamination of the skin)",
"     </li>",
"     <li>",
"      Picking is performed in full awareness",
"     </li>",
"     <li>",
"      There is some resistance to performing it",
"     </li>",
"     <li>",
"      There is some insight into the senselessness or harmfulness of the behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Taking ample time to interview the patient is useful to reveal any underlying psychiatric disorder. Some patients may spontaneously report a concomitant psychiatric illness at presentation. Others may be reluctant to reveal their diagnosis or do not have a previous diagnosis. Psychiatric referral may be considered in difficult cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H572775\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic skin picking should be differentiated from excoriations seen in patients with primary pruritic skin disorders, or in patients with systemic conditions associated with chronic pruritus. Other psychocutaneous syndromes associated with self-injurious behavior, including dermatitis artefacta, delusion of parasitosis, and body dysmorphic disorder, should be differentiated from primary PSP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/4/3145?source=see_link\">",
"     \"Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18457059\">",
"    <span class=\"h2\">",
"     Primary skin disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with pruritic skin diseases may present with psychiatric disorders, most often depression or anxiety disorders, which are secondary to the skin disease. Preoccupation with poor quality of life, decreased self-esteem and self-confidence, experience of rejection, and feelings of shame or guilt may be present in patients with chronic skin conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/5,22\">",
"     5,22",
"    </a>",
"    ]. The skin disease may affect interpersonal relationships and interactions and lead to social avoidance [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/5,22\">",
"     5,22",
"    </a>",
"    ]. In addition, the itch-scratch cycle in these patients can be triggered or exacerbated by stressors, such as psychological stress or environmental changes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary pruritic dermatoses include atopic dermatitis, psoriasis, scabies, and bullous pemphigoid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atopic dermatitis is characterized by thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules (",
"      <a class=\"graphic graphic_picture graphicRef64525 graphicRef55375 \" href=\"UTD.htm?31/48/32520\">",
"       picture 2A-B",
"      </a>",
"      ). The diagnosis of atopic dermatitis is supported by: a history or visible evidence of itchy dermatitis involving the flexural surfaces (",
"      <a class=\"graphic graphic_picture graphicRef57982 \" href=\"UTD.htm?6/56/7045\">",
"       picture 3",
"      </a>",
"      ), a history of symptoms beginning in infancy or childhood, and the presence of generally dry skin within the past year. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psoriasis is often associated with pruritus. It is not restricted to the area of the psoriatic plaque, often being generalized and poorly responsive to antipruritics. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Scabies is caused by the mite Sarcoptes scabiei, which lays its eggs in the epidermal layer of human skin. The outstanding clinical feature of scabies is intense itching. It is often severe and usually worse in the evening and night. Lesions may appear as small, erythematous papules or nodules, often excoriated with hemorrhagic crust (",
"      <a class=\"graphic graphic_picture graphicRef75169 \" href=\"UTD.htm?9/30/9697\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link&amp;anchor=H5#H5\">",
"       \"Scabies\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link&amp;anchor=H67764214#H67764214\">",
"       \"Scabies\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bullous pemphigoid is an autoimmune subepidermal blistering disease occurring most frequently in elderly individuals. Bullous pemphigoid may present in a subgroup of patients with pruritus and an eruption similar to prurigo nodularis (pemphigoid nodularis) (",
"      <a class=\"graphic graphic_picture graphicRef69828 \" href=\"UTD.htm?39/16/40192\">",
"       picture 5",
"      </a>",
"      ). A skin biopsy for histologic examination and direct immunofluorescence, and the measurement of circulating autoantibodies against BP antigens confirm the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=see_link\">",
"       \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18457251\">",
"    <span class=\"h2\">",
"     Systemic diseases associated with chronic pruritus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several systemic conditions may be associated with intense and persistent pruritus, in the absence of primary skin disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/24\">",
"     24",
"    </a>",
"    ]. Secondary skin changes including nodular lesions similar to prurigo nodularis, eczematization, excoriation, and lichenification can be observed in patients with: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Uremia",
"     </li>",
"     <li>",
"      Cholestasis and primary biliary cirrhosis &nbsp;",
"     </li>",
"     <li>",
"      Polycythemia vera",
"     </li>",
"     <li>",
"      Lymphoma",
"     </li>",
"     <li>",
"      Solid tumors",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      Iron deficiency",
"     </li>",
"     <li>",
"      HIV infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/54/10090?source=see_link&amp;anchor=H690865#H690865\">",
"     \"Pruritus: Etiology and patient evaluation\", section on 'Systemic disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18457259\">",
"    <span class=\"h2\">",
"     Other psychocutaneous syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other psychocutaneous syndromes that should be differentiated from PSP include dermatitis artefacta, delusions of parasitosis, and body dysmorphic disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dermatitis artefacta is a psychocutaneous disorder in which patients intentionally induce skin lesions in order to simulate disease and assume the patient role. The lesions of dermatitis artefacta usually appear at an identical stage of development, can be single or multiple, are often geometric, unilateral or bilateral, and generally within reach of the hands (",
"      <a class=\"graphic graphic_picture graphicRef76670 graphicRef55697 graphicRef67422 \" href=\"UTD.htm?30/45/31449\">",
"       picture 6A-C",
"      </a>",
"      ). The lesions can be created by the use of sharp instruments, or applying or injecting chemical substances into the skin. Characteristically, patients describe the sudden appearance of complete lesions, with little or no prodrome (&ldquo;hollow history&rdquo;), and usually deny taking part in the process, exhibiting a &ldquo;belle indifference&rdquo; and lack of frustration despite the recurrent nature of their symptomatology [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=see_link\">",
"       \"Factitious disorder and Munchausen syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Delusions of parasitosis is a rare disorder in which affected individuals have the fixed, false belief (delusion) that their skin is infested by parasites. No obvious skin disease may be present, but excoriations frequently result from the patient&rsquo;s attempt to extract the imaginary parasites. Patients often bring in specimens for examination, which they have picked from their skin and may include scabs or cloth fibers, but do not include parasites. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/4/3145?source=see_link\">",
"       \"Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Body dysmorphic disorder or dysmorphophobia is a disturbance of the body image manifesting as a preoccupation with an imagined or exaggerated defect in physical appearance. Skin picking is common among patients with body dysmorphic disorder. Approximately one third of patients compulsively pick at their skin, trying to remove minor blemishes or otherwise clear or perfect their skin [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/27\">",
"       27",
"      </a>",
"      ]. Patients often report multiple dermatologic consultations and express dissatisfaction with previous treatments.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211844\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical, psychiatric, and PSP-related history should be elicited from patients with pathologic skin picking. Physical examination should include a thorough dermatologic evaluation to assess the severity of excoriation, the presence of complications (scarring, infections), or coexistent primary skin disorders associated with chronic pruritus, including atopic dermatitis, prurigo nodularis, psoriasis, scabies, or bullous pemphigoid. (See",
"    <a class=\"local\" href=\"#H572775\">",
"     'Differential diagnosis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H18457059\">",
"     'Primary skin disorders'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients with PSP, psychiatric referral is strongly encouraged, although many patients will not readily accept referral.",
"   </p>",
"   <p>",
"    For patients with primary pruritic skin disease and secondary psychiatric disorders, therapy includes optimal treatment of the skin disorder, symptom-targeted therapy, psychopharmacologic, and nonpharmacologic psychiatric therapy.",
"   </p>",
"   <p>",
"    If a medical or organic cause is suspected to be the underlying etiology of chronic pruritus and skin picking, appropriate workup should be instituted to rule out organ dysfunction, nutritional deficiencies, or malignancies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/54/10090?source=see_link&amp;anchor=H690865#H690865\">",
"     \"Pruritus: Etiology and patient evaluation\", section on 'Systemic disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211851\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of PSP involves three elements: optimization of the patient&rsquo;s mental state in terms of insight, motivation and awareness; pharmacologic; and nonpharmacologic therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/28\">",
"     28",
"    </a>",
"    ]. Patients with PSP should be managed by clinicians who have expertise in the use of psychotropic medications as well as topical medications. This may require either comanagement by a mental health specialist and dermatologist, or management by a specialist who has experience in both psychiatric and dermatologic disorders. The treatment plan should be based upon a thorough discussion with the patient, and should include close monitoring for both clinical efficacy and adverse effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7747779\">",
"    <span class=\"h2\">",
"     Dermatologic therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of PSP, including skin infection or disfigurement, may require medical, surgical, or cosmetic intervention. Topical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic antibiotics may be prescribed to treat secondarily infected excoriations or ulcerations. Semi-occlusive dressings may be useful to limit further skin damage and promote healing. Laser treatment for scars has been used in case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/29\">",
"     29",
"    </a>",
"    ]. In patients with PSP and associated pruritus, potent topical corticosteroids (group 1 to 3) (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 2",
"    </a>",
"    ) or intralesional glucocorticoids such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide are commonly used and appear to provide benefit, although there are no published studies of efficacy. Phototherapy with narrow-band UVB has been reported as beneficial in reducing pruritus and skin picking behaviors in a small series of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/30\">",
"     30",
"    </a>",
"    ]. For patients with acne excori&eacute;e, appropriate treatment of the underlying acne should be initiated, depending on acne severity and type. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39370?source=see_link\">",
"     \"Treatment of acne vulgaris\"",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Our general approach to treatment of the excoriated skin with significant pruritus is to initiate therapy with a high potency corticosteroid for nonfacial lesions, and taper the potency of the topical steroid as response is observed. Secondary infections and symptoms of pruritus should be addressed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link\">",
"     \"Pruritus: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7747794\">",
"    <span class=\"h2\">",
"     Antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;When pharmacotherapy is selected for the treatment of PSP, we suggest initial treatment with selective serotonin reuptake inhibitor (SSRI) antidepressants, which include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    . SSRIs have been shown to be efficacious in the treatment of obsessive-compulsive disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/31\">",
"     31",
"    </a>",
"    ]. However, SSRIs for PSP have been evaluated only in a limited number of small clinical trials and case series, some with significant dropout rates and wide confidence intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/32-36\">",
"     32-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SSRIs should generally be started at their minimal effective dose:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    20 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    20 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    20 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    10 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    50 mg, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    50 mg. The dose can be increased every week or every other week, as tolerated. The clinical response to the SSRI antidepressants is gradual. Patients showing no response at six to eight weeks may be switched to another class of antidepressants.",
"   </p>",
"   <p>",
"    Common SSRI side effects include sexual dysfunction, drowsiness, weight gain, insomnia, anxiety, dizziness, headache, and dry mouth. When discontinuing an SSRI, a slow taper is advised, due to withdrawal symptoms such as nausea, diaphoresis, agitation, anxiety, dizziness, and sensory problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H399779802#H399779802\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Prescribing SSRIs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H399779851#H399779851\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7747801\">",
"    <span class=\"h2\">",
"     Antipsychotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antipsychotics may be helpful in selected patients with PSP, particularly in delusional patients. The first-line option is the typical antipsychotic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6472?source=see_link\">",
"     pimozide",
"    </a>",
"    , a centrally acting dopamine receptor antagonist, at a dose of 4 mg per day. It is the most common treatment for delusions of parasitosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1575?source=see_link&amp;anchor=H12625596#H12625596\">",
"     \"Treatment of delusional parasitosis\", section on 'Antipsychotic medication'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The atypical antipsychotic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    is a dopamine and serotonin receptor antagonist. Olanzapine 2.5 to 5 mg per day, either alone or with an antidepressant, has been shown to reduce PSP behaviors in case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7747808\">",
"    <span class=\"h2\">",
"     Anxiolytics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anxiolytics may be used when the underlying cause of PSP is an anxiety disorder, although there are no specific studies of the use of anxiolytic drugs in the treatment of PSP.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     Lorazepam",
"    </a>",
"    is a shorter acting benzodiazepine that can be dosed at 0.5 to 1.0 mg four times daily as needed, depending on the severity of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/41\">",
"     41",
"    </a>",
"    ]. Treatment duration should be short-term due to the risk of dependency. The most common side effect is sedation. If the anxiety disorder is chronic,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"     buspirone",
"    </a>",
"    at doses of 10 to 30 mg twice daily may be helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=see_link\">",
"     \"Pharmacotherapy for generalized anxiety disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7747815\">",
"    <span class=\"h2\">",
"     Behavioral treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive and behavioral therapies may be beneficial for patients accepting psychiatric referral. However, only a limited number of observational studies and randomized trials have examined non-pharmacologic therapeutic options for PSP, including cognitive-behavioral therapy, habit reversal therapy, and acceptance enhanced behavior therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a randomized trial, 34 college students were randomly assigned to treatment with a four-session course of cognitive-behavioral treatment or a waiting list control group [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/45\">",
"     45",
"    </a>",
"    ]. Skin picking severity measures (skin picking scale, skin picking impact scale, and self-control cognition questionnaire) decreased significantly in the treatment group compared to the control group. Treatment effects were maintained at two months after the end of treatment. &nbsp;",
"   </p>",
"   <p>",
"    In another trial, 25 adults were randomly assigned to a habit reversal treatment (one hour treatment session followed by two 30-minute booster sessions over the next three weeks) or a waiting list, and followed-up for three months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13080/abstract/43\">",
"     43",
"    </a>",
"    ]. The number of skin picking episodes decreased significantly over time in the treatment group, compared to the waiting list group. Benefits were maintained at three-month follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15211858\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pathologic skin picking (PSP) is the repetitive manipulation of the skin, with or without instrumentation, resulting in visible tissue damage and impairment in social functioning. Patients with PSP may present with features of impulse control disorder, obsessive compulsive disorder, or both (",
"      <a class=\"graphic graphic_table graphicRef67010 \" href=\"UTD.htm?29/16/29964\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Multiple psychiatric comorbidities are associated with PSP, including depression, bipolar disorder, obsessive compulsive disorder, alcohol abuse or dependance, and trichotillomania. (See",
"      <a class=\"local\" href=\"#H15211830\">",
"       'Comorbid conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PSP appears as excoriated, polymorphic lesions of variable size in all stages of evolution, localized most frequently on the face (",
"      <a class=\"graphic graphic_picture graphicRef60854 graphicRef72635 graphicRef53693 graphicRef61686 \" href=\"UTD.htm?15/52/16202\">",
"       picture 1A-D",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15211837\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PSP is supported by a list of diagnostic criteria (",
"      <a class=\"graphic graphic_table graphicRef67010 \" href=\"UTD.htm?29/16/29964\">",
"       table 1",
"      </a>",
"      ). PSP should be differentiated from the excoriations seen in subgroups of patients with primary pruritic skin conditions, chronic pruritus associated with systemic diseases, or other psychocutaneous diseases. (See",
"      <a class=\"local\" href=\"#H572775\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Psychiatric referral is appropriate for patients with PSP, although many patients will not accept it. Patients with PSP should be either comanaged by a mental health specialist and dermatologist, or managed by a specialist who has experience in both psychiatric and dermatologic disorder. (See",
"      <a class=\"local\" href=\"#H15211844\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with associated intense pruritus, we suggest potent topical corticosteroids (group 1 to 3) (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 2",
"      </a>",
"      ) or intralesional",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      acetonide (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with acne excori&eacute;e, aggressive treatment of the underlying acne should be initiated. Patients with skin infections should be treated with topical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      systemic antibiotics. (See",
"      <a class=\"local\" href=\"#H7747779\">",
"       'Dermatologic therapies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest pharmacotherapy for patients with skin picking behavior whose severity interferes with daily functioning (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). When pharmacotherapy is selected for the treatment of PSP, we suggest an SSRI antidepressant (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Evidence is limited, but we typically initiate treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      20 mg per day, titrating the dose up every two to four weeks as needed and tolerated. In patients presenting with features of delusional disorder, antipsychotic medications are indicated.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6472?source=see_link\">",
"       Pimozide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      are options, but have only been reported in case studies. (See",
"      <a class=\"local\" href=\"#H7747794\">",
"       'Antidepressants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7747801\">",
"       'Antipsychotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients accepting mental health professional referral, we suggest cognitive behavioral-therapy or habit reversal therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7747815\">",
"       'Behavioral treatments'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/1\">",
"      Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15:351.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/3\">",
"      Keuthen NJ, Koran LM, Aboujaoude E, et al. The prevalence of pathologic skin picking in US adults. Compr Psychiatry 2010; 51:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/4\">",
"      Hayes SL, Storch EA, Berlanga L. Skin picking behaviors: An examination of the prevalence and severity in a community sample. J Anxiety Disord 2009; 23:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/5\">",
"      Keuthen NJ, Deckersbach T, Wilhelm S, et al. Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics 2000; 41:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/6\">",
"      Bohne A, Wilhelm S, Keuthen NJ, et al. Skin picking in German students. Prevalence, phenomenology, and associated characteristics. Behav Modif 2002; 26:320.",
"     </a>",
"    </li>",
"    <li>",
"     Griesemer, RD. Emotionally triggered disease in a dermatologic practice. Psychiatr Ann 1978; 8:407.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/8\">",
"      Gupta MA, Gupta AK, Haberman HF. The self-inflicted dermatoses: a critical review. Gen Hosp Psychiatry 1987; 9:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/9\">",
"      Odlaug BL, Grant JE. Childhood-onset pathologic skin picking: clinical characteristics and psychiatric comorbidity. Compr Psychiatry 2007; 48:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/10\">",
"      Odlaug BL, Grant JE. Clinical characteristics and medical complications of pathologic skin picking. Gen Hosp Psychiatry 2008; 30:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/11\">",
"      Arnold LM, McElroy SL, Mutasim DF, et al. Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry 1998; 59:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/12\">",
"      Neziroglu F, Rabinowitz D, Breytman A, Jacofsky M. Skin picking phenomenology and severity comparison. Prim Care Companion J Clin Psychiatry 2008; 10:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/13\">",
"      Wilhelm S, Keuthen NJ, Deckersbach T, et al. Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry 1999; 60:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/14\">",
"      Mutasim DF, Adams BB. The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol 2009; 61:611.",
"     </a>",
"    </li>",
"    <li>",
"     Obermeyer, ME. Psychocutaneous Medicine, Charles C Thomas, Springfield, IL 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/16\">",
"      Parent DJ, Krafft T, Noel JC, et al. Cutaneous M&uuml;nchausen syndrome with presentation simulating pyoderma gangrenosum. J Am Acad Dermatol 1994; 31:1072.",
"     </a>",
"    </li>",
"    <li>",
"     Koblenzer, CS. Psychocutaneous Disease, Grune and Stratton, New York 1987.",
"    </li>",
"    <li>",
"     Mackee, GM. Neurotic excoriations. Arch Dermatol Syphilol 1920; 1:256.",
"    </li>",
"    <li>",
"     Panconesi, E. Dermatologically expressed psychiatric syndromes. Clin Dermatol 1984; 2:205.",
"    </li>",
"    <li>",
"     Koblenzer, CS. Psychotropic drugs in dermatology. Curr Opinion Dermatol 1996; 3:214.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/21\">",
"      Phillips KA, Taub SL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull 1995; 31:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/22\">",
"      Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007; 9:203.",
"     </a>",
"    </li>",
"    <li>",
"     Koo JY, Lee CS. General approach to evaluating psychodermatological disorders. In: Psychocutaneous Medicine, Koo JY, Lee CS (Eds), Dekker, New York 2003. p.1.",
"    </li>",
"    <li>",
"     Graves MW. Pruritus. In: Rook's Textbook of Dermatology, 8th Edition, Burns T, Breathnach  S, Cox N., Griffiths C.  (Eds), Wiley-Blackwell, Oxford, UK 2010. Vol 1.",
"    </li>",
"    <li>",
"     Hurwitz Clinical Pediatric Dermatology, 3rd Ed, Paller AS, Mancini AJ.  (Eds), Elsevier Inc., Philadelphia, PA 2006. p.678.",
"    </li>",
"    <li>",
"     Millard LG and Millard J. Psychocutaneous disorders. In: Rooks's Textbook of Dermatology, 8th Edition, Burns T, Breathnach S, Cox N, Griffiths C.  (Eds), Wiley-Blackwell, 2010. Vol 4.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/27\">",
"      Phillips KA, Dufresne RG. Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons. Am J Clin Dermatol 2000; 1:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/28\">",
"      Koo JY, Ng TC. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications. Clin Dermatol 2002; 20:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/29\">",
"      Bowes LE, Alster TS. Treatment of facial scarring and ulceration resulting from acne excori&eacute;e with 585-nm pulsed dye laser irradiation and cognitive psychotherapy. Dermatol Surg 2004; 30:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/30\">",
"      Ozden MG, Aydin F, Sent&uuml;rk N, et al. Narrow-band ultraviolet B as a potential alternative treatment for resistant psychogenic excoriation: an open-label study. Photodermatol Photoimmunol Photomed 2010; 26:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/31\">",
"      Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008; :CD001765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/32\">",
"      Simeon D, Stein DJ, Gross S, et al. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry 1997; 58:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/33\">",
"      Bloch MR, Elliott M, Thompson H, Koran LM. Fluoxetine in pathologic skin-picking: open-label and double-blind results. Psychosomatics 2001; 42:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/34\">",
"      Arbabi M, Farnia V, Balighi K, et al. Efficacy of citalopram in treatment of pathological skin picking, a randomized double blind placebo controlled trial. Acta Medica Iranica 2008; 46:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/35\">",
"      Keuthen NJ, Jameson M, Loh R, et al. Open-label escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol 2007; 22:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/36\">",
"      Kalivas J, Kalivas L, Gilman D, Hayden CT. Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol 1996; 132:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/37\">",
"      Damiani JT, Flowers FP, Pierce DK. Pimozide in delusions of parasitosis. J Am Acad Dermatol 1990; 22:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/38\">",
"      Holmes VF. Treatment of monosymptomatic hypochondriacal psychosis with pimozide in an AIDS patient. Am J Psychiatry 1989; 146:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/39\">",
"      Garnis-Jones S, Collins S, Rosenthal D. Treatment of self-mutilation with olanzapine. J Cutan Med Surg 2000; 4:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/40\">",
"      Gupta MA, Gupta AK. Olanzapine is effective in the management of some self-induced dermatoses: three case reports. Cutis 2000; 66:143.",
"     </a>",
"    </li>",
"    <li>",
"     Lee CS, Koo JY. Psychotropic agents. In: Comprehensive Dermatologic Drug Therapy, 2nd ed, Wolverton SE (Ed), Elsevier, London 2007. p.402.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/42\">",
"      Deckersbach T, Wilhelm S, Keuthen NJ, et al. Cognitive-behavior therapy for self-injurious skin picking. A case series. Behav Modif 2002; 26:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/43\">",
"      Teng EJ, Woods DW, Twohig MP. Habit reversal as a treatment for chronic skin picking: a pilot investigation. Behav Modif 2006; 30:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/44\">",
"      Flessner CA, Busch AM, Heideman PW, Woods DW. Acceptance-enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif 2008; 32:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13080/abstract/45\">",
"      Schuck K, Keijsers GP, Rinck M. The effects of brief cognitive-behaviour therapy for pathological skin picking: A randomized comparison to wait-list control. Behav Res Ther 2011; 49:11.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13698 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-B869A8C837-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13080=[""].join("\n");
var outline_f12_49_13080=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15211858\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211814\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44169844\">",
"      DEFINITION AND CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211823\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211830\">",
"      COMORBID CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211837\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44169867\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H572775\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18457059\">",
"      Primary skin disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18457251\">",
"      Systemic diseases associated with chronic pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18457259\">",
"      Other psychocutaneous syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211844\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211851\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7747779\">",
"      Dermatologic therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7747794\">",
"      Antidepressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7747801\">",
"      Antipsychotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7747808\">",
"      Anxiolytics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7747815\">",
"      Behavioral treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15211858\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13698\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13698|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/2/19491\" title=\"picture 1A\">",
"      Pathologic skin picking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/13/30928\" title=\"picture 1B\">",
"      Pathologic skin picking 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/13/21713\" title=\"picture 1C\">",
"      Pathologic skin picking abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/54/1888\" title=\"picture 1D\">",
"      Pathologic skin picking arm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/21/40272\" title=\"picture 1E\">",
"      Pathologic skin picking face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/39/24178\" title=\"picture 1F\">",
"      Pathologic skin picking back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/20/8518\" title=\"picture 1G\">",
"      Acne excoriee",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/31/24051\" title=\"picture 2A\">",
"      Adult atopic dermatitis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/10/42147\" title=\"picture 2B\">",
"      Adult atopic dermatitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/56/7045\" title=\"picture 3\">",
"      Atopic dermatitis antecubit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/30/9697\" title=\"picture 4\">",
"      Scabies buttocks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/16/40192\" title=\"picture 5\">",
"      Bullous pemphigoid 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/3/7221\" title=\"picture 6A\">",
"      Factitial dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/60/22464\" title=\"picture 6B\">",
"      Factitial dermatitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/14/24800\" title=\"picture 6C\">",
"      Factitial dermatitis 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13698|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/16/29964\" title=\"table 1\">",
"      Pathologic skin picking diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 2\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/4/3145?source=related_link\">",
"      Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=related_link\">",
"      Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=related_link\">",
"      Pharmacotherapy for generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/54/10090?source=related_link\">",
"      Pruritus: Etiology and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=related_link\">",
"      Pruritus: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39370?source=related_link\">",
"      Treatment of acne vulgaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1575?source=related_link\">",
"      Treatment of delusional parasitosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=related_link\">",
"      Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_49_13081="Travel advice for immunocompromised hosts";
var content_f12_49_13081=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Travel advice for immunocompromised hosts",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Camille N Kotton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13081/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/49/13081/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunocompromised hosts represent a broad spectrum of immune compromise. Severely immunocompromised patients include individuals with active leukemia or lymphoma, generalized malignancy, aplastic anemia, graft-versus-host disease, congenital immunodeficiency, on current or recent radiation therapy, solid organ transplant within a year, or bone marrow transplant within two years, or individuals whose transplants occurred &gt;2 years ago but who are still taking immunosuppressive drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/1\">",
"     1",
"    </a>",
"    ]. Moderately immunocompromised patients include individuals with asplenia, renal failure, chronic liver disease, or diabetes.",
"   </p>",
"   <p>",
"    Immunocompromised hosts traveling overseas are at risk for exposure to endemic pathogens. In general, the vaccine response rate in these patients is diminished and they may be more likely to have adverse effects from vaccines containing live attenuated virus. In addition, vaccines are immunomodulatory and may impact immunologic conditions.",
"   </p>",
"   <p>",
"    Issues related to travel-related vaccines in adult immunocompromised hosts without HIV will be reviewed here. Issues related to travel-related vaccines in immunocompetent hosts are discussed separately, as are issues related to routine immunizations for these groups. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=see_link\">",
"     \"Immunizations for travel\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=see_link\">",
"     \"Immunizations after hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=see_link\">",
"     \"Immunizations in patients with cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link\">",
"     \"Immunizations in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunocompromised hosts planning to travel overseas should be evaluated by a travel medicine specialist familiar with the patient's immunocompromised state and medications [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Travel health specialists for complex patients should confer with the traveler's other providers as needed to develop an appropriate plan.",
"   </p>",
"   <p>",
"    Among 95 transplant recipients with recent travel outside North America, 66 percent of travelers sought pre-travel advice from their transplant physician and many of the recommended preventative measures were overlooked: 63 percent traveled to areas where hepatitis A is endemic, but only 5 percent had received hepatitis A immunization; 50 percent traveled to dengue and malaria endemic areas, but only 25 percent adhered to mosquito prevention measures; and 10 percent reported behaviors that exposed them to blood or body fluids [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the broad spectrum of immune compromise, an assessment of risk is an important part of the pretravel visit (",
"    <a class=\"graphic graphic_table graphicRef56079 \" href=\"UTD.htm?25/22/25964\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Some immunocompromised hosts may wish to defer travel until they are less immunocompromised (eg, delay until 1 year after SOT or 2 years after HCT).",
"   </p>",
"   <p>",
"    Vaccination should be initiated several months prior to travel when possible to allow time for serologic testing and additional boosters if needed. Ideally, immunocompromised hosts should be vaccinated during periods of minimal or no exogenous immunosuppression (eg, before solid organ or hematopoietic stem cell transplant, before biologic immunomodulators are given, etc) to optimize the immunologic response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Vaccination is least effective in the initial months after solid organ or hematopoietic stem cell transplant since this is usually the period of highest immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link\">",
"     \"Immunizations in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, a fourfold increase in antibody titer (or titer above a designated threshold) is considered evidence of seroconversion. Immunocompromised hosts are less likely to have a significant immunologic response, although they may benefit from partial protection.",
"   </p>",
"   <p>",
"    Immune responses to vaccination may wane more rapidly in immunocompromised individuals than other hosts. Booster doses of vaccine may be administered in the setting of low or undetectable antibody titers, although the efficacy for this has not been demonstrated.",
"   </p>",
"   <p>",
"    The response to vaccination can be variable. Among 292 allogeneic transplant recipients, 89 percent of those who failed to mount a response to the recombinant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/36/27207?source=see_link\">",
"     hepatitis B vaccine",
"    </a>",
"    mounted a &ge;threefold rise in polio titers following three doses of inactivated poliovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/9\">",
"     9",
"    </a>",
"    ]. Studies on the efficacy or seroconversion following most travel vaccines in immunocompromised hosts have not been performed.",
"   </p>",
"   <p>",
"    It may be prudent to avoid vaccine adjuvants in allogeneic transplant recipients since these may alter host immunologic tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ROUTINE VACCINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Travel advice encounters provide the opportunity to review routine immunizations that may have been overlooked. Information on routine vaccinations in immunocompromised hosts is summarized in the Tables (",
"    <a class=\"graphic graphic_table graphicRef66152 \" href=\"UTD.htm?23/58/24493\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59497 \" href=\"UTD.htm?19/58/20397\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef62130 \" href=\"UTD.htm?41/17/42263\">",
"     figure 1",
"    </a>",
"    ) and discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link\">",
"     \"Immunizations in solid organ transplant candidates and recipients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=see_link\">",
"     \"Immunizations after hematopoietic cell transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=see_link\">",
"     \"Immunizations in patients with cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Tetanus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tetanus boosters should be up to date before traveling. Tetanus is rare in the industrialized world where vaccination rates are quite good; the prevalence is much higher in resource limited settings although it is rare among travelers. Vaccination is appropriate for travelers to regions where tetanus is endemic who were vaccinated more than 10 years previously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diphtheria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diphtheria is common in resource limited settings. Vaccination is appropriate for travelers to regions where diphtheria is endemic who were vaccinated more than 10 years previously or whose titers are below &gt;0.1",
"    <span class=\"nowrap\">",
"     IU/mL.",
"    </span>",
"    In practice, boosters are frequently given without checking titers. Diphtheria antibody levels could be measured &ge;4 weeks after vaccination for immunocompromised travelers traveling to endemic areas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pertussis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Booster vaccination for pertussis is warranted for previously vaccinated adults. Acellular Tdap vaccines have been formulated for adults with reduced quantities of the diphtheria and pertussis to reduce side effects (available as Boostrix&trade; or ADACEL&trade;). Thus far this vaccine has not been studied in immunocompromised hosts, but may be used in the setting of exposure risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=see_link\">",
"     \"Treatment and prevention of Bordetella pertussis infection in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccination against influenza should occur annually in most immunocompromised hosts; exceptions include those who underwent transplantation, treatment for rejection, or other profound immunosuppression in the few months prior to vaccination. Influenza immunity wanes and it is not known whether immunocompromised travelers should be given booster vaccines prior to travel. Given the year-round influenza activity in the tropics, in general standard practice is to revaccinate prior to travel if it has been more than 12 months since the last influenza vaccine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pneumococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pneumococcal vaccine should be given to immunocompromised hosts. In trials comparing PCV-7 to PPV-23 in renal transplant recipients, there was no difference in immunogenicity between the vaccines [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/13\">",
"     13",
"    </a>",
"    ]. Revaccination should be performed once, 3 to 5 years after initial immunization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Measles, mumps, and rubella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccination against measles, mumps and rubella in the United States is usually performed with a trivalent live virus vaccine (MMR vaccine). Primary and acquired immunodeficiency states are contraindications to MMR vaccination, including patients who are immunosuppressed in with human immunodeficiency virus, cellular immune deficiencies, and hypogammaglobulinemic and dysgammaglobulinemic states [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. Measles inclusion body encephalitis (MIBE), pneumonitis, and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MMR vaccine may be administered to patients with asplenia, renal failure, chronic liver disease, and diabetes but not to those with more severe immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/1\">",
"     1",
"    </a>",
"    ]. Prior to travel to endemic areas, serologic evidence of immunity against measles, mumps and rubella should be evaluated in transplant recipients. Immune globulin should be considered for seronegative immunosuppressed travelers to areas where measles is endemic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14822?source=see_link\">",
"     \"Measles-mumps-rubella vaccination in high risk adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunocompromised hosts with hypogammaglobulinemia or other medical conditions and who routinely receive intravenous immunoglobulin (IVIG) do not need additional gamma globulin protection for measles, varicella, or hepatitis A, as the IVIG is likely to provide much higher titer protection than gamma globulin. Vaccination against hepatitis A should still be performed for longer term protection (albeit a lower peak serologic titer and shorter duration of protection will be achieved than in normal hosts).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunization against hepatitis B is appropriate for certain immunocompromised hosts including HCT recipients (given their exposure to blood products), those who will have new sexual partners while traveling, those living in endemic areas for extended periods, or those who are likely to need transfusions or medical procedures while traveling.",
"   </p>",
"   <p>",
"    The efficacy of standard hepatitis B vaccination is reduced when the vaccine is administered following transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/15,16,20\">",
"     15,16,20",
"    </a>",
"    ]. Response rates appear to be adversely affected by age &ge;18 years and history of prior chronic graft versus host disease but not by donor type, T-cell depletion, adoptive immunotherapy, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The serologic response rate can be improved by administering extra doses of vaccine with an adjuvant or by intradermal vaccination followed by an intramuscular booster [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Some favor the following regimen: immunization with a vaccine containing 40 mcg of hepatitis B surface antigen (ie, two 1 mL Engerix-B vaccines, each containing 20 mcg, or a special formulation of Recombivax-HB) at one site, in a three dose schedule [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18,23\">",
"     18,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Varicella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic evidence of immunity against varicella should be evaluated in transplant recipients prior to travel to endemic areas. In general, the attenuated live Oka strain vaccine formulations for varicella should not be used in immunocompromised hosts until there are more data regarding their safety. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/28/4551?source=see_link\">",
"     varicella vaccine",
"    </a>",
"    may be administered to individuals with asplenia, renal failure, chronic liver disease, and diabetes but not to those with more severe immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14822?source=see_link\">",
"     \"Measles-mumps-rubella vaccination in high risk adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immune globulin should be considered for seronegative, severely immunosuppressed travelers to areas where varicella is endemic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18\">",
"     18",
"    </a>",
"    ]. Immunocompromised hosts with hypogammaglobulinemia who receive routine intravenous immunoglobulin (IVIG) do not need additional antibody protection for varicella, measles or hepatitis A.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TRAVEL VACCINES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hepatitis A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis A can be a devastating illness in immunocompromised hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/24\">",
"     24",
"    </a>",
"    ]. These patients have attenuated immunologic response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/30/44518?source=see_link\">",
"     hepatitis A vaccine",
"    </a>",
"    and shortened durability [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Seroconversion rates may depend on severity of disease, immunosuppressive medications, and type of vaccine used [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. In one series including 39 liver and 39 renal transplant recipients who received two doses of hepatitis A vaccine six months apart, response rates among liver transplant recipients were 41 and 97 percent and response rates among renal transplant recipients were 24 and 72 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intramuscular gamma globulin (consisting of pooled immunoglobulins) is 85 to 90 percent protective against hepatitis A infection; this effect lasts for 3 to 6 months, depending on the dose given. Immunocompromised hosts with hypogammaglobulinemia who receive routine intravenous immunoglobulin (IVIG) do not need additional antibody protection for hepatitis A, measles, or varicella.",
"   </p>",
"   <p>",
"    In general, vaccination with two doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/30/44518?source=see_link\">",
"     hepatitis A vaccine",
"    </a>",
"    6 to 12 months apart may be reasonable for SOT recipients who underwent transplantation at least a year previously and are on a modest immunosuppressive regimen, if there is enough time before travel. Titers may be checked to document seroconversion, although this adds expense and there is often insufficient time to document seroconversion prior to travel.",
"   </p>",
"   <p>",
"    SOT recipients and other moderately to significantly immunosuppressed hosts who do not have sufficient time for immunization prior to travel or do not respond to immunization can be given intramuscular immunoglobulin prior to travel [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18\">",
"     18",
"    </a>",
"    ]. For less immunocompromised hosts, vaccination alone may be adequate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Salmonella enterica serovar Typhi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 300 to 400 cases of typhoid fever are reported in the United States each year; most are related to international travel [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/30\">",
"     30",
"    </a>",
"    ]. Immunocompromised individuals may have severe complications during infection with Salmonella enterica serovar Typhi and should be immunized against typhoid prior to travel to endemic areas.",
"   </p>",
"   <p>",
"    There are two vaccines available: TyphimVi (Aventis Pasteur SA), an injectable polysaccharide vaccine, and Vivotif (Ty21a, Berna) an oral live, attenuated vaccine. Both are generally well tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/31\">",
"     31",
"    </a>",
"    ]. The inactive parenteral vaccine is recommended for immunocompromised individuals, as the oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/7/25718?source=see_link\">",
"     typhoid vaccine",
"    </a>",
"    is a live vaccine that can cause disseminated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/32\">",
"     32",
"    </a>",
"    ]. The immune response in immunocompromised hosts to either vaccine is usually poor and efficacy in immunocompromised hosts is unknown. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/58/18345?source=see_link\">",
"     \"Treatment and prevention of typhoid fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Polio",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poliomyelitis due to wild-type poliovirus has been eradicated from the Western hemisphere; wild type virus exists in sub-Saharan Africa and South Asia. Outbreaks of vaccine-associated poliomyelitis occasionally occur due to reversion of live attenuated poliovirus from the oral polio vaccine. Such outbreaks have occurred in Hispaniola (Haiti and the Dominican Republic), the Philippines, Madagascar, and Cape Verde.",
"   </p>",
"   <p>",
"    Two forms of polio vaccine are available: the orally administered, live, attenuated virus (OPV or Sabin), and the injected inactivated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/58/35749?source=see_link\">",
"     poliovirus vaccine",
"    </a>",
"    (IPV or Salk). Immunocompromised hosts and household contacts of immunocompromised individuals should not receive OPV, since attenuated vaccine strain polioviruses may spread through fecal-oral contact. OPV is no longer distributed in the United States and Canada.",
"   </p>",
"   <p>",
"    In generals, travelers should have received a primary series of polio vaccine during childhood and at least one booster as an adult. Some authorities recommend booster immunization if more than ten years have elapsed since administration of the last polio vaccine, especially for individuals traveling to areas of the world with circulating wild-type polio viruses or a polio outbreak.",
"   </p>",
"   <p>",
"    Poliovirus immunity is relatively well maintained after revaccination among patients with allogeneic SCT. In a study of 134 patients who received three doses of inactivated polio vaccine beginning 12 months after HSCT, the estimated probabilities of remaining immune to poliovirus at 5 and 10 years after vaccination were 94 and 94 percent for subtype 1, 98 and 94 percent for subtype 2, and 93 and 90 percent for subtype 3, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/33\">",
"     33",
"    </a>",
"    ]. Patients with chronic GVHD to lost immunity more rapidly than those without GVHD. Response to vaccination after SOT has not been well studied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17223?source=see_link\">",
"     \"Poliovirus vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Meningococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningococcal disease has high case-fatality rate (5 to 15 percent). The meningococcal vaccine is indicated for individuals traveling to areas of the world with known outbreaks of invasive meningococcal disease, to the meningitis belt of sub-Saharan Africa (especially during the dry winter months of December through June), and to Saudi Arabia for the Muslim pilgrimages of Hajj or Umrah, where proof of vaccination is required.",
"   </p>",
"   <p>",
"    Immunocompromised hosts are at increased risk for morbidity and mortality from meningococcal disease; vaccination is appropriate for those with exposure risk. In the United States a quadrivalent polysaccharide (Neisseria meningitidis A, C, Y, W-135) vaccine and a newer protein conjugate vaccine are available. Persons who previously were vaccinated at age &ge;7 years and are at prolonged increased risk (ie, asplenia, other immunocompromised states) should be revaccinated &le;5 years after their previous meningococcal vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among 44 adult HSCT recipients randomized to receive meningococcal vaccine either 8 or 20 months after transplant, the majority had significant immune responses to serogroups A and C; these responses were lower in the former group (8 months) than the latter group (20 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/35\">",
"     35",
"    </a>",
"    ]. The immune responses declined sharply over the first 6 to 12 months after vaccination, suggesting revaccination should be performed for those at risk of exposure to meningococcal infection. Chronic GVHD had no influence on the vaccination response.",
"   </p>",
"   <p>",
"    Among 38 pediatric HSCT recipients 100 percent response to meningococcal serogroup C was observed 2 to 4 weeks after vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/36\">",
"     36",
"    </a>",
"    ]. Among 25 pediatric oncology patients, response to meningococcal C-conjugate vaccine was variable; those with lower serologic response rates were more likely to be receiving chemotherapy or have lower B cell counts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no published data regarding the response of solid organ transplant recipients to immunization with the polysaccharide or protein conjugate meningococcal vaccine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=see_link\">",
"     \"Meningococcal vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Yellow fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yellow fever is a mosquito-borne viral hemorrhagic fever that occurs in tropical regions of South America and sub-Saharan Africa. Case fatality may surpass 20 percent; no specific treatment exists.",
"   </p>",
"   <p>",
"    In general, immunocompromised travelers should avoid regions where yellow fever is endemic. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/13/14550?source=see_link\">",
"     yellow fever vaccine",
"    </a>",
"    contains a live attenuated viral strain, and as a rule this vaccine should not be administered to immunocompromised hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/15,18,38-42\">",
"     15,18,38-42",
"    </a>",
"    ]. The CDC guidelines suggest that yellow fever vaccine can be given to those with asplenia, renal failure, chronic liver disease, and diabetes but not to those with more severe immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thymic dysfunction has been found to be an independent risk factor for the development of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/13/14550?source=see_link\">",
"     yellow fever vaccine",
"    </a>",
"    -associated viscerotropic disease, and health care providers should ask about a history of thymus disorder, including myasthenia gravis, thymoma or prior thymectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/43\">",
"     43",
"    </a>",
"    ]. Fatal myeloencephalitis following yellow fever vaccination have been reported in immunosuppressed individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunocompromised travelers who cannot avoid travel to endemic regions should be counseled to avoid traveling during peak seasons for yellow fever transmission and minimize exposure to mosquitoes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some mildly immunosuppressed individuals have tolerated the vaccine (including individuals with early HIV infection or a distant history of hematological malignancy without recent immunosuppressive therapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/47-50\">",
"     47-50",
"    </a>",
"    ]. In a retrospective study of 70 patients with rheumatologic conditions who received the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/13/14550?source=see_link\">",
"     yellow fever vaccine",
"    </a>",
"    in Brazil, 23 percent reported some minor adverse effect; this rate is comparable to adverse reactions among immunocompetent individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Final decision regarding vaccination should be made with careful consideration of risks and benefits. For patients who cannot avoid travel to endemic regions but do not receive vaccination, a physician's letter stating contraindications to vaccination with the stamp of an official, approved yellow fever immunization center is acceptable to most governments. Some countries may deny entry without immunization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/21/15705?source=see_link\">",
"     \"Yellow fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidates for pre-exposure immunization against rabies include travelers expecting intense animal exposure, travelers planning to be far from medical care, and long-term travelers.",
"   </p>",
"   <p>",
"    Immunocompromised hosts may not mount adequate antibody responses to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    (titers &gt;0.5",
"    <span class=\"nowrap\">",
"     IU/mL);",
"    </span>",
"    efficacy data for rabies data are minimal in SOT and HSCT recipients. It may be reasonable to administer rabies vaccination to individuals with significant exposure risks factors, although human rabies immunoglobulin (HRIG) should also be administered after all risk exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20088?source=see_link\">",
"     \"When to use rabies prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Japanese encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunization against Japanese encephalitis is appropriate for individuals traveling to rural areas of Asia where JE is endemic, especially during periods of increased transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18,53\">",
"     18,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5208?source=see_link\">",
"     \"Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Bacille Calmette-Guerin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacille Calmette-Guerin (BCG) is a live, attenuated strain of M. bovis, prevention of tuberculosis. BCG should not be administered to immunocompromised host as it can cause disseminated infection.",
"   </p>",
"   <p>",
"    Immunocompromised hosts may wish to wear masks when in healthcare settings in areas endemic for tuberculosis. Pre- and post-travel tuberculosis skin tests with the purified protein derivative (PPD) may be performed but are likely to be negative in the immunocompromised population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PROPHYLAXIS AND PREVENTIVE MEASURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Travelers' diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrhea affects 10 to 60 percent of travelers to developing regions. Travelers' diarrhea may be life threatening for immunocompromised hosts. Dehydration may compromise renal function and increase toxicity of immunosuppressants such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    . Complications of diarrhea may include bacteremia and altered intestinal absorption (with concomitant alterations in the absorption of oral immunosuppressive medications).",
"   </p>",
"   <p>",
"    Travelers should be counseled regarding appropriate food and water precautions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18\">",
"     18",
"    </a>",
"    ]. In general, travelers should drink boiled or bottled beverages and avoid raw foods (except fruit and vegetables that can be peeled). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=see_link\">",
"     \"Travel advice\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Travelers should carry antimicrobials such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    for self treatment of diarrheal illness lasting more than one to two days (",
"    <a class=\"graphic graphic_table graphicRef61057 \" href=\"UTD.htm?5/37/5724\">",
"     table 4",
"    </a>",
"    ). Patients with fever, vomiting,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bloody stools should consider seeking medical attention.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    is not effective against travelers' diarrhea due to microbial resistance.",
"   </p>",
"   <p>",
"    Antimotility agents may delay clearance of toxins from the gut.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     Bismuth",
"    </a>",
"    subsalicylate (ie, Pepto-Bismol) is converted to salicylic acid and insoluble bismuth salts in the gastrointestinal tract; immunocompromised hosts with decreased renal function may be at higher risk for salicylate toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29145?source=see_link\">",
"     \"Travelers' diarrhea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaria is a significant risk for travelers to endemic areas. Asplenic patients should be aware of their potential increased morbidity and mortality from malaria. There is no evidence that malaria is significantly more common or severe in other immunocompromised hosts apart from HIV infected individuals; issues related to malaria and HIV infection are discussed in detail separately [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/8/3209?source=see_link\">",
"     \"HIV and malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunocompromised hosts should be instructed on ways to minimize insect bites, including use of repellents containing DEET (N,N-diethyl-3-methylbenzamide), bed nets, protective clothing, and permethrin-impregnated clothing [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/18\">",
"     18",
"    </a>",
"    ]. Prophylaxis against malaria should be based on the travel itinerary; this is discussed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef61057 \" href=\"UTD.htm?5/37/5724\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=see_link\">",
"     \"Prevention of malaria infection in travelers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Respiratory infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endemic fungal pulmonary infections such as histoplasmosis and coccidioidomycosis (in North America) and penicilliosis due to Penicillium marneffei infection (in Southeast Asia) could be acquired during travel [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/55\">",
"     55",
"    </a>",
"    ]. SOT recipients are at increased risk for invasive fungal infection and should avoid activities such as spelunking and excavating, which have been associated with exposure to Cryptococcus neoformans or endemic fungi. Use of masks may be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Sun",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transplant recipients have a markedly increased risk of skin cancer which correlates with the intensity of sun exposure. It is important to recommend the use of hats, sunglasses, protective clothing (also useful for arthropod-borne infections), and sun protection lotions with ultraviolet A and B protection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Altitude",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence that altitude sickness is more common or severe in immunocompromised hosts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=see_link\">",
"     \"Travel advice\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Close contacts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthy individuals who undergo vaccination with live, attenuated vaccine strains can transmit infection to immunocompromised hosts. In general, use of certain live virus vaccines (including oral polio, live attenuated (nasal) influenza, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/24/18823?source=see_link\">",
"     smallpox vaccine",
"    </a>",
"    ) should be deferred in close contacts of immunocompromised hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/1\">",
"     1",
"    </a>",
"    ]. Other live vaccines such as measles, mumps, rubella, yellow fever, oral Salmonella, varicella (Varivax), and zoster (Zostavax) vaccines are less likely to be transmitted and may be given to close contacts of immunocompromised hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     TRANSPLANT TOURISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transplant tourism refers to travel for the purpose of receiving or donating a transplanted organ [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/57\">",
"     57",
"    </a>",
"    ]. The number of transplants for US national waiting list candidates performed in foreign countries has been increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/58\">",
"     58",
"    </a>",
"    ]. Between 2001 and 2006, 373 patients were removed from US national waiting lists due to transplants performed abroad; 89 percent were kidney transplants. Recipients received foreign transplant in 35 countries, led by China, the Philippines, and India [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/58\">",
"     58",
"    </a>",
"    ]. The majority are \"commercial transplants\", which include payment to the donor. International transplant organizations have made efforts to decrease purchase and sale of organs on ethical grounds [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The extent and quality of the pre-transplant evaluation of the donor and recipient may be variable and the quality of serologic evaluation may be substandard, and prophylactic measures may be incomplete [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/45\">",
"     45",
"    </a>",
"    ]. Foreign-born transplant recipients who return to their country of origin for organ transplants are at risk both for reactivation of latent infections as well as acquisition of new infections [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/45,60-66\">",
"     45,60-66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study comparing 540 recipients of commercial renal transplants in India with 75 recipients of emotionally related renal transplants in the Middle East, the incidence of both human immune deficiency virus (HIV) infection and hepatitis B virus infection was increased (5 and 8 percent versus 0 and 1 percent, respectively percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Among 115 recipients of commercial renal transplants in India, Iraq, and Iran, the posttransplant course was complicated by malaria (10 cases), invasive fungal infections (5 cases) and tuberculosis (5 cases), and pneumonia due to various opportunistic pathogens [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13081/abstract/63\">",
"       63",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When commercial transplant recipients return to transplant centers in industrialized countries, it is prudent to screen for blood-borne pathogens (including HIV, HBV, and HCV), as well as bacteremia, urinary tract infection, and other endemic pathogens depending on their clinical course (malaria, tuberculosis, Chagas disease, etc). Optimizing their post-transplant prophylaxis against infection and obtaining further information about their surgical procedure(s) and immunosuppression may also help optimize their care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunocompromised hosts are vulnerable to infection and may have a diminished immunologic response to vaccination. Such patients planning to travel overseas should be evaluated by a travel medicine specialist familiar with the patient's immunocompromised state and medications. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Travel advice encounters provide the opportunity to review routine immunizations which may have been overlooked. These include tetanus, diphtheria, pertussis, influenza, pneumococcus, measles, mumps, rubella, hepatitis B and varicella. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Routine vaccines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate travel vaccines depend on the individual itinerary but may include typhoid, polio, meningococcus, rabies, and Japanese encephalitis. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Travel vaccines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following live vaccines are generally contraindicated in immunocompromised hosts: measles, mumps, rubella, varicella, yellow fever, and Bacille Calmette-Guerin. Immunoglobulin may provide protection against measles, mumps, rubella, varicella, hepatitis A and rabies when vaccination is contraindicated or there is insufficient time to develop immunity. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Routine vaccines'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Travel vaccines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic and preventive measures are warranted for illnesses that cannot be prevented by vaccination. These include travelers diarrhea, malaria and other arthropod borne illnesses, respiratory infection, sun exposure and altitude. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Prophylaxis and preventive measures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transplant tourism (travel for the purpose of receiving or donating a transplanted organ) is increasing. When commercial transplant recipients return to transplant centers in industrialized countries, it is prudent to screen for blood-borne pathogens (including HIV, HBV, and HCV), as well as bacteremia, urinary tract infection, and other endemic pathogens depending on their clinical course (malaria, tuberculosis, Chagas disease, etc). (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Transplant tourism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-8/immunocompromised-traveler.aspx (Accessed on May 18, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/2\">",
"      Boggild AK, Sano M, Humar A, et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004; 11:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/3\">",
"      Roukens AH, van Dissel JT, de Fijter JW, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant 2007; 21:567.",
"     </a>",
"    </li>",
"    <li>",
"     Advising Travelers with Specific Needs: The Immunocompromised Traveler. file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-8-advising-travelers-with-specific-needs/immunocompromised-travelers.htm (Accessed on September 17, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/5\">",
"      Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007; 33:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/6\">",
"      Elkayam O, Caspi D, Reitblatt T, et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004; 33:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/7\">",
"      van der Velden AM, Claessen AM, van Velzen-Blad H, et al. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine 2007; 25:8512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/8\">",
"      Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/9\">",
"      Jaffe D, Papadopoulos EB, Young JW, et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood 2006; 108:2470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/10\">",
"      Magnani G, Falchetti E, Pollini G, et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant 2005; 24:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/11\">",
"      Nevens F, Zuckerman JN, Burroughs AK, et al. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients. Liver Transpl 2006; 12:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/12\">",
"      Rosenau J, Hooman N, Rifai K, et al. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int 2006; 19:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/13\">",
"      Kumar D, Welsh B, Siegal D, et al. Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial. Am J Transplant 2007; 7:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/14\">",
"      Danzinger-Isakov L, Kumar D, AST Infectious Diseases Community of Practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9 Suppl 4:S258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/15\">",
"      Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/16\">",
"      Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001; 33 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/17\">",
"      Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001; 15:273.",
"     </a>",
"    </li>",
"    <li>",
"     CDC. Health information for international travel 2011-2012. DHHS, Atlanta, GA 2011.",
"    </li>",
"    <li>",
"     file://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf (Accessed on May 18, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/20\">",
"      Hayney MS, Welter DL, Reynolds AM, et al. High-dose hepatitis B vaccine in patients waiting for lung transplantation. Pharmacotherapy 2003; 23:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/21\">",
"      Bienzle U, G&uuml;nther M, Neuhaus R, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/22\">",
"      Choy BY, Peiris JS, Chan TM, et al. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2002; 2:965.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention Adult Immunization Schedule 2009. file://www.cdc.gov/vaccines/recs/schedules/adult-schedule.htm (Accessed on December 25, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/24\">",
"      Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med 2000; 342:1716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/25\">",
"      G&uuml;nther M, Stark K, Neuhaus R, et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001; 71:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/26\">",
"      Rendi-Wagner P, Korinek M, Winkler B, et al. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 2007; 25:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/27\">",
"      Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001; 72:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/28\">",
"      Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/29\">",
"      Stark K, G&uuml;nther M, Neuhaus R, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999; 180:2014.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.who.int/vaccine_research/diseases/diarrhoeal/en/index7.html.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/31\">",
"      Begier EM, Burwen DR, Haber P, et al. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis 2004; 38:771.",
"     </a>",
"    </li>",
"    <li>",
"     file://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/typhoid-paratyphoid-fever.aspx (Accessed on May 18, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/33\">",
"      Ljungman P, Aschan J, Gustafsson B, et al. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant 2004; 34:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/34\">",
"      Centers for Disease Control and Prevention (CDC). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep 2009; 58:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/35\">",
"      Parkkali T, K&auml;yhty H, Lehtonen H, et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant 2001; 27:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/36\">",
"      Patel SR, Ort&iacute;n M, Cohen BJ, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/37\">",
"      Yu JW, Borkowski A, Danzig L, et al. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients. Pediatr Blood Cancer 2007; 49:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/38\">",
"      Cetron MS, Marfin AA, Julian KG, et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/39\">",
"      Fishman JA. Smallpox and live-virus vaccination in transplant recipients. Am J Transplant 2003; 3:786.",
"     </a>",
"    </li>",
"    <li>",
"     Ljungman P. Vaccination of Transplant Recipients. In: Transplant Infections, Bowden RA, Ljungman P, Paya CV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2003. p.611.",
"    </li>",
"    <li>",
"     Mileno M. Preparation of Immunocompromised Travelers. In: Travel Medicine, 1st ed, Keystone JS, Freedman DP, Nothdurft HD, Connor BA (Eds), Mosby, Edinburgh 2004. p.249.",
"    </li>",
"    <li>",
"     https://www.vaccineshoppe.com/image.cfm?doc_id=5991&amp;image_type=product_pdf (Accessed on May 18, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/43\">",
"      Domingo C, Niedrig M. Safety of 17D derived yellow fever vaccines. Expert Opin Drug Saf 2009; 8:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/44\">",
"      Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/45\">",
"      Kennedy SE, Shen Y, Charlesworth JA, et al. Outcome of overseas commercial kidney transplantation: an Australian perspective. Med J Aust 2005; 182:224.",
"     </a>",
"    </li>",
"    <li>",
"     file://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/yellow-fever-vaccine-requirements-and-recommendations.aspx.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/47\">",
"      Gowda R, Cartwright K, Bremner JA, Green ST. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/48\">",
"      Receveur MC, Thi&eacute;baut R, Vedy S, et al. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases. Clin Infect Dis 2000; 31:E7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/49\">",
"      Tattevin P, Depatureaux AG, Chapplain JM, et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS 2004; 18:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/50\">",
"      Ho YL, Enohata T, Lopes MH, De Sousa Dos Santos S. Vaccination in Brazilian HIV-infected adults: a cross-sectional study. AIDS Patient Care STDS 2008; 22:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/51\">",
"      Mota LM, Oliveira AC, Lima RA, et al. [Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases]. Rev Soc Bras Med Trop 2009; 42:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/52\">",
"      Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA 2001; 285:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/53\">",
"      Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     Conlon CP. The Immunocompromised Traveler. In: Textbook of Travel Medicine and Health, 2nd ed, DuPont HL, Steffer R (Eds), BC Decker, 2001. p.464.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/55\">",
"      Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002; 35:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/56\">",
"      Marin M, G&uuml;ris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/57\">",
"      Evans RW. Ethnocentrism is an unacceptable rationale for health care policy: a critique of transplant tourism position statements. Am J Transplant 2008; 8:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/58\">",
"      Merion RM, Barnes AD, Lin M, et al. Transplants in Foreign Countries Among Patients Removed from the US Transplant Waiting List. Am J Transplant 2008; 8:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/59\">",
"      Participants in the International Summit on Transplant Tourism and Organ Trafficking Convened by the Transplantation Society and International Society of Nephrology in Istanbul, Turkey, April 30-May 2, 2008. The Declaration of Istanbul on organ trafficking and transplant tourism. Transplantation 2008; 86:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/60\">",
"      Mart&iacute;n-D&aacute;vila P, Fort&uacute;n J, L&oacute;pez-V&eacute;lez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 2008; 21:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/61\">",
"      Commercially motivated renal transplantation: results in 540 patients transplanted in India. The Living Non-Related Renal Transplant Study Group. Clin Transplant 1997; 11:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/62\">",
"      Harling R, Turbitt D, Millar M, et al. Passage from India: an outbreak of hepatitis B linked to a patient who acquired infection from health care overseas. Public Health 2007; 121:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/63\">",
"      Sever MS, Kazanciolu R, Yildiz A, et al. Outcome of living unrelated (commercial) renal transplantation. Kidney Int 2001; 60:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/64\">",
"      Canales MT, Kasiske BL, Rosenberg ME. Transplant tourism: Outcomes of United States residents who undergo kidney transplantation overseas. Transplantation 2006; 82:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/65\">",
"      Geddes CC, Henderson A, Mackenzie P, Rodger SC. Outcome of patients from the west of Scotland traveling to Pakistan for living donor kidney transplants. Transplantation 2008; 86:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13081/abstract/66\">",
"      Gill J, Madhira BR, Gjertson D, et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 2008; 3:1820.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3896 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-23EAA62341-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13081=[""].join("\n");
var outline_f12_49_13081=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ROUTINE VACCINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Tetanus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diphtheria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pertussis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Influenza",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pneumococcus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Measles, mumps, and rubella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Varicella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TRAVEL VACCINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hepatitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Salmonella enterica serovar Typhi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Polio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Meningococcus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Yellow fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Rabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Japanese encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Bacille Calmette-Guerin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PROPHYLAXIS AND PREVENTIVE MEASURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Travelers' diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Malaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Respiratory infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Sun",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Altitude",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Close contacts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      TRANSPLANT TOURISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3896\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3896|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/17/42263\" title=\"figure 1\">",
"      Vaccine schedule based on medical conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3896|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/22/25964\" title=\"table 1\">",
"      Spectrum of immune compromise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/58/24493\" title=\"table 2\">",
"      Travel vaccines for SOT travelers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/58/20397\" title=\"table 3\">",
"      Vaccines for HCT recipients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/37/5724\" title=\"table 4\">",
"      Medication interactions travel and transplant",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=related_link\">",
"      BCG vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/8/3209?source=related_link\">",
"      HIV and malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=related_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=related_link\">",
"      Immunizations after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2394?source=related_link\">",
"      Immunizations for travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=related_link\">",
"      Immunizations in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=related_link\">",
"      Immunizations in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=related_link\">",
"      Immunizations in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5208?source=related_link\">",
"      Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14822?source=related_link\">",
"      Measles-mumps-rubella vaccination in high risk adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=related_link\">",
"      Meningococcal vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17223?source=related_link\">",
"      Poliovirus vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=related_link\">",
"      Prevention of malaria infection in travelers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=related_link\">",
"      Travel advice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29145?source=related_link\">",
"      Travelers' diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=related_link\">",
"      Treatment and prevention of Bordetella pertussis infection in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/58/18345?source=related_link\">",
"      Treatment and prevention of typhoid fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20088?source=related_link\">",
"      When to use rabies prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/21/15705?source=related_link\">",
"      Yellow fever",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_49_13082="Neuroimaging in the evaluation of seizures and epilepsy";
var content_f12_49_13082=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Neuroimaging in the evaluation of seizures and epilepsy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Lawrence J Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Hiba Arif, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Timothy A Pedley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/49/13082/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/49/13082/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/49/13082/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term epileptic seizure refers to a transient occurrence of signs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    symptoms due to abnormally excessive neuronal activity of the cerebral cortex. Epilepsy is a condition characterized by recurrent, unprovoked seizures. The diagnosis of epilepsy is often not straightforward, and misdiagnosis is not rare [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/1\">",
"     1",
"    </a>",
"    ]. A detailed and reliable account of the event by an eyewitness is crucial to the diagnostic evaluation, but may not be available [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The purpose of the diagnostic evaluation in a patient with seizures is to provide evidence that helps confirm or refute the diagnosis of epilepsy and to identify the cause of epilepsy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to classify the epileptic syndrome. Neuroimaging also has a critical role in the evaluation of patients with refractory epilepsy for epilepsy surgery.",
"   </p>",
"   <p>",
"    This topic will discuss neuroimaging in the diagnostic evaluation of adults with possible epileptic seizures. Other aspects of diagnostic testing for seizures and epilepsy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=see_link\">",
"     \"Clinical and laboratory diagnosis of seizures in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=see_link\">",
"     \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15368?source=see_link\">",
"     \"Video and ambulatory EEG monitoring in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPUTED TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is commonly ordered in patients presenting with new-onset seizure to an emergency department. It is generally available quickly in that setting and can exclude acute neurologic problems that require urgent intervention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, in non-emergent situations, magnetic resonance imaging is more sensitive than CT and is the neuroimaging study of choice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MAGNETIC RESONANCE IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients suspected of having had an epileptic seizure should have a neuroimaging study. The purpose is to identify a structural etiology for epilepsy. The mainstay of elective neuroimaging is magnetic resonance imaging (MRI), which is more sensitive than computed tomography for most epileptogenic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exceptions to the need for neuroimaging include children with simple febrile seizures and children whose clinical history and EEG are consistent with benign partial epilepsy of childhood or idiopathic generalized epilepsy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link\">",
"     \"Febrile seizures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=see_link\">",
"     \"Benign partial epilepsies of childhood\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=see_link\">",
"     \"Epilepsy syndromes in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Specific pathologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural causes of epilepsy that can be identified by MRI include [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mesial temporal sclerosis (hippocampal sclerosis) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77659 graphicRef69972 \" href=\"UTD.htm?19/10/19623\">",
"       image 1A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malformations of cortical development (eg, cortical dysplasia) (",
"      <a class=\"graphic graphic_table graphicRef62398 \" href=\"UTD.htm?42/46/43755\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65171 \" href=\"UTD.htm?14/43/15027\">",
"       image 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Brain tumors",
"     </li>",
"     <li>",
"      Vascular malformations",
"     </li>",
"     <li>",
"      Cerebral infarction, cerebral hemorrhage",
"     </li>",
"     <li>",
"      Traumatic brain injury",
"     </li>",
"     <li>",
"      Infections, including encephalitis, cerebral abscess, granulomas, and cysts (neurocysticercosis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mesial temporal sclerosis, also known as hippocampal sclerosis is the most commonly diagnosed focal structural abnormality in patients with epilepsy. While most cases present in childhood, it is not uncommon for this disorder to first appear in young adults. Surgical treatment is often curative in patients who do not become seizure-free on medication. MRI characteristics include hippocampal atrophy and increased T2 and FLAIR signal intensity (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77659 \" href=\"UTD.htm?6/2/6179\">",
"     image 1A",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69972 \" href=\"UTD.htm?7/58/8097\">",
"     image 1B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=see_link&amp;anchor=H3#H3\">",
"     \"Localization-related (partial) epilepsy: Causes and clinical features\", section on 'Mesial temporal sclerosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41593?source=see_link\">",
"     \"Surgical therapy of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malformations of cortical development (eg, focal cortical dysplasia) (",
"    <a class=\"graphic graphic_table graphicRef62398 \" href=\"UTD.htm?42/46/43755\">",
"     table 1",
"    </a>",
"    ) are the second most common structural etiology for epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. As neuroimaging has become more sophisticated, these are being identified in a greater number of epilepsy patients. MRI is more sensitive for focal cortical dysplasias with more severe pathologic grade than for milder lesions, and these are more amenable to surgical cure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Subtle findings of focal cortical thickening may be missed on initial interpretation of the MRI and identified when the study is re-reviewed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/9\">",
"     9",
"    </a>",
"    ]. These lesions are congenital, and related epilepsy usually presents in childhood. However, it is not rare for epilepsy to first develop in young adults.",
"   </p>",
"   <p>",
"    Brain tumors and cerebrovascular disease are more common in older patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40841?source=see_link\">",
"     \"Seizures and epilepsy in the elderly patient: Etiology, clinical presentation, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain infections, especially neurocysticercosis caused by Taenia solium, are common etiologies of epilepsy in endemic populations. When neurocysticercosis is suspected, MRI with contrast is useful for identifying cysts and evaluating disease activity. However, computed tomography (CT) may add to the diagnostic evaluation, as CT is more sensitive than MRI for detecting small areas of calcification. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cysticercosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15413?source=see_link\">",
"     \"Epidemiology, transmission and prevention of cysticercosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals with new-onset epilepsy will not have a structural lesion on MRI; in one case series, the yield was 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/6\">",
"     6",
"    </a>",
"    ]. Among reported studies, a wide range (1 to 57 percent) of neuroimaging studies in patients with epilepsy are abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/5,12-15\">",
"     5,12-15",
"    </a>",
"    ]. These differences reflect the technology used (eg, CT versus MRI), the patient population studied, and the range of MRI abnormalities included as abnormal. As an example, emergency department-based studies include a larger number with acute symptomatic seizures that are more likely to have corresponding CT or MRI abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/12\">",
"     12",
"    </a>",
"    ]. Also, older patient populations are more likely to have structural brain lesions identified on MRI as a cause for epilepsy than are populations of primarily younger adults.",
"   </p>",
"   <p>",
"    While brain MRI is routinely used in the clinical evaluation of epilepsy, there remains a substantial gap between the sensitivity and specificity of MRI in different care settings [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/9,16\">",
"     9,16",
"    </a>",
"    ]. In one study, 123 patients referred for epilepsy surgery evaluation had had a \"standard\" MRI at an outside center (not attached to an epilepsy center) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/16\">",
"     16",
"    </a>",
"    ]. The original MRI interpretation was compared to a reinterpretation of the original MRI and also to the results of a repeat MRI performed using a dedicated epilepsy protocol. The sensitivity of MRI for focal lesions for each of these was 39, 50, and 91 percent respectively. This was a select patient population of patients with refractory epilepsy that excluded patients with acute focal brain conditions, including cerebral abscess and rapidly expanding brain tumors. In most cases, the missed diagnosis was hippocampal sclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Epilepsy protocol for MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;To optimize the yield, MRI should be performed using an epilepsy protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3,4,17\">",
"     3,4,17",
"    </a>",
"    ]. While epilepsy protocols vary depending on the institution and available technology, most recommendations agree that an epilepsy protocol for MRI should ideally include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Standard T1-weighted images.",
"     </li>",
"     <li>",
"      T2-weighted fast spin-echo sequences.",
"     </li>",
"     <li>",
"      Gradient echo (T2) sequences. Sensitive for small hemosiderin deposits, these may detect smaller cavernous malformations or prior traumatic brain injury.",
"     </li>",
"     <li>",
"      Fluid-attenuated inversion recovery (FLAIR) sequences.",
"     </li>",
"     <li>",
"      3D volume acquisition sequences with high definition of the gray-white junction (eg, magnetization-prepared rapid acquisition gradient echo (MPRAGE); 3D fast spoiled gradient recalled echo acquisition at steady state (3D fast spoiled GRASS or 3D-SPGR)). These help identify cortical dysplasia and allow 3D reconstruction and volumetrics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Imaging sequences should consist of contiguous, thin (&lt;1.5 mm) slices that cover the entire brain. All the above sequences should be obtained in two orthogonal planes, with coronal images obtained obliquely to be oriented perpendicular to the hippocampus. The oblique coronal orientation minimizes partial volume effects that otherwise commonly obscure hippocampal sclerosis and small lesions in the temporal lobe. The use of gadolinium is not required for initial diagnostic MRI studies, but can be used to better define pathologies seen on noncontrast study or to improve sensitivity in initially-negative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/4,18\">",
"     4,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4070890\">",
"    <span class=\"h4\">",
"     Advanced MRI techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensitivity also appears to be improved by more advanced MRI technologies that are not universally available at present. One study found that the use of phased-array surface coil MRI performed at 3-Tesla MRI detected focal lesions in 65 percent of patients with a previously negative MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/19\">",
"     19",
"    </a>",
"    ]. Findings included cortical dysplasia, benign tumors, and hippocampal sclerosis. In one-third of patients with a prior abnormal MRI, the 3-Tesla MRI study further characterized the lesion's pathology and anatomic extent. Other reports confirm the superiority of higher field strength imaging study [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diffusion tensor imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/22-24\">",
"     22-24",
"    </a>",
"    ], magnetization transfer imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/25\">",
"     25",
"    </a>",
"    ], voxel-based analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/26\">",
"     26",
"    </a>",
"    ], and T2-mapping [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] are other new technologies that show promise in the improved detection of both hippocampal sclerosis and malformations of cortical development. More recently, susceptibility-weighted imaging (SWI; a technique that exploits the magnetic properties of tissues, such as blood or hemosiderin content) has been shown to be significantly more sensitive in detecting cavernous malformations compared to both T2-weighted fast spin-echo and gradient-echo sequences [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/29\">",
"     29",
"    </a>",
"    ]. This technique also appears to be helpful in identifying epileptogenic, postinfectious, calcified lesions (eg, cryptococcus, tuberculosis, cysticercosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-resolution MRI is required for the diagnosis of many malformations of cortical development. On a standard MRI, findings suggestive of dysplasia include cortical thickening, blurring of the gray-white margin, increased signal on FLAIR, and subtle tapering bands of gray matter extending from the cortex towards the ventricles (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65171 \" href=\"UTD.htm?14/43/15027\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/31\">",
"     31",
"    </a>",
"    ]. Subtle lesions can be missed, and false positive MRI readings can result from over-interpretation of normal variations in cortical thickness [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specialized MRI techniques such as magnetization transfer imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/25\">",
"     25",
"    </a>",
"    ], diffusion tensor imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/22,32\">",
"     22,32",
"    </a>",
"    ], voxel-based analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/26,33\">",
"     26,33",
"    </a>",
"    ], and texture analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] improve detection of malformations of cortical development as well as MRI's ability to detect the full extent of the malformation. The latter is important because complete removal correlates with successful remission of seizures after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Specificity of MRI findings for epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not all MRI abnormalities are associated with epileptic seizures. Punctate foci of T2 signal change in the white matter, many cystic lesions (arachnoid cysts, choroidal fissure cysts), lacunar strokes, ventricular asymmetry, diffuse atrophy, and isolated venous anomalies (ie, those not associated with arteriovenous malformation or cavernous angioma) are not known to be epileptogenic, and should be considered incidental to a seizure diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When a potentially epileptogenic structural abnormality is seen on brain MRI, it suggests an anatomic substrate for epilepsy, and provides support for a diagnosis of epilepsy. However, such findings should not be interpreted in isolation and must be correlated with the patient's seizure semiology and EEG findings. Several observations suggest that such findings might be incidental in a small proportion of patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with idiopathic generalized epilepsy, MRI abnormalities have been reported in up to 24 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. While most of these findings were not epileptogenic (eg, arachnoid cyst, diffuse cortical atrophy, etc.), potentially epileptogenic lesions were seen in 3 to 4 percent. Similarly, one series reported abnormal MRI findings in 15 percent of 71 children with clinical and EEG features of benign childhood epilepsy with centrotemporal spikes [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/39\">",
"       39",
"      </a>",
"      ]. Less than half of these findings were potentially epileptogenic. The benign course of these children's epilepsy syndromes suggests that these findings were truly incidental.",
"     </li>",
"     <li>",
"      In patients with psychogenic nonepileptic seizures, an abnormal brain MRI is reported in 10 to 38 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/40-44\">",
"       40-44",
"      </a>",
"      ]. Again, some, but not all of these abnormalities were epileptogenic, such as post-traumatic gliosis and hippocampal sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study comparing brain MRIs in 51 healthy controls and 99 patients with temporal lobe epilepsy, increased signal was noted in one or both hippocampi in 29 percent of controls (compared to 47.5 percent of patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/45\">",
"       45",
"      </a>",
"      ]. Hippocampal atrophy was a more specific finding, noted in only one control subject versus 19 percent of patients; no control had both atrophy and increased signal in the same hippocampus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=see_link&amp;anchor=H3#H3\">",
"       \"Localization-related (partial) epilepsy: Causes and clinical features\", section on 'Mesial temporal sclerosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In normal, healthy adult volunteers, intracranial abnormalities were observed in 4.2 percent in one study of 1000 individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/46\">",
"       46",
"      </a>",
"      ]. Pathologies included those that were potentially epileptogenic (tumors, remote trauma), as well as those that were not (arachnoid cyst, empty sella, lacunar infarction). This study may have underestimated the prevalence of relevant abnormalities, especially mesial temporal sclerosis, as these MRIs were not done as an epilepsy protocol.",
"     </li>",
"     <li>",
"      Among 207 patients screened with high resolution MRI for hearing loss, two studies revealed hippocampal sclerosis; both patients had previously diagnosed epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/47\">",
"       47",
"      </a>",
"      ]. The presence or absence of other MRI findings were not mentioned in this report.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another potential source of diagnostic confusion is that some patients may have acute MRI changes that are attributed to the effect of seizures rather than their cause. These are more common after prolonged seizures or clusters of seizures, and are characterized by local swelling, increased T2 signal intensity, restricted diffusion, and focal parenchymal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    leptomeningeal contrast enhancement that resolve on subsequent imaging studies. These are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22871?source=see_link\">",
"     \"Magnetic resonance imaging changes related to acute seizure activity\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FUNCTIONAL MAGNETIC RESONANCE IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional MRI (fMRI) can detect focal changes in blood flow and oxygenation levels that occur when an area of the brain is activated. A change in the level of neuronal activity is accompanied by a change in the ratio of concentration of oxy- to deoxyhemoglobin in the blood measured on MRI as the blood-oxygen-level-dependent (BOLD) effect. fMRI can be used to noninvasively map motor, sensory, and language functions, and is most commonly used as part of surgical planning to predict and limit postoperative neurologic deficits, particularly language function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/48-55\">",
"     48-55",
"    </a>",
"    ]. fMRI may eventually replace the carotid amobarbital (Wada) test, particularly for language lateralization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/56\">",
"     56",
"    </a>",
"    ]. With regard to memory function, early work suggests that fMRI may be able to visualize the functional anatomy of memory tasks, and may eventually assist decision-making and planning of epilepsy surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/52,57-64\">",
"     52,57-64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41593?source=see_link\">",
"     \"Surgical therapy of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interpretation of fMRI requires caution; it is an indirect measure of brain function. Discrepancies with the Wada test have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/65-68\">",
"     65-68",
"    </a>",
"    ]. Its sensitivity and specificity are imperfect (84 and 88 percent compared to the Wada test, in one analysis), particularly in extratemporal epilepsy, and analyses have not been standardized [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/69\">",
"     69",
"    </a>",
"    ]. Also, some patients cannot complete fMRI or have inconclusive fMRI results and still require preoperative Wada testing [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Simultaneous recording of EEG and fMRI can visualize the BOLD response during interictal or ictal epileptic activity. This emerging technique could assist in identifying targets for surgical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/70-78\">",
"     70-78",
"    </a>",
"    ]. However, the utility of fMRI for this purpose is not yet established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POSITRON EMISSION TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) images the topographic distribution of glucose uptake in the brain and provides a picture of cerebral metabolism. Ictal scans can be useful but are difficult to obtain except in rare cases such as epilepsia partialis continua. Thus, FDG-PET scans are typically performed in the interictal state, with the goal of detecting focal areas of decreased metabolism, ie, relative hypometabolism, that are presumed to reflect focal functional disturbances of cerebral activity associated with epileptogenic tissue. FDG-PET is generally performed as part of a presurgical evaluation.",
"   </p>",
"   <p>",
"    Sensitivity for detecting relative temporal lobe hypometabolism with FDG-PET in mesial temporal lobe epilepsy (MTLE) ranges between 80 and 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3,79-85\">",
"     3,79-85",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75459 \" href=\"UTD.htm?0/28/453\">",
"     image 3",
"    </a>",
"    ). Much of the variability in sensitivity reflects the heterogeneity of the epilepsy more than it does the differences in quality or specifications of the PET camera [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/86\">",
"     86",
"    </a>",
"    ]. Some reports suggest that the sensitivity of PET is increased when seizures are more frequent or when performed soon after a seizure has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a few patients in the above series included patients with MTLE without hippocampal sclerosis on MRI. However, these and other series have shown that FDG-PET can be helpful in lateralizing the epileptogenic temporal lobe in \"MRI-negative\" cases, with a yield that ranges from 45 to almost 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/79-83,88-91\">",
"     79-83,88-91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is less information available regarding the usefulness of FDG-PET in extratemporal epilepsy, but it appears somewhat less sensitive in these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3,12,80,92-95\">",
"     3,12,80,92-95",
"    </a>",
"    ]. An exception may be patients with cortical dysplasia, in whom the reported sensitivity of PET varies between 60 and 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/96\">",
"     96",
"    </a>",
"    ]. Another limitation of PET is that the area of hypometabolism typically extends beyond the epileptogenic zone, making it less useful for precise neuroanatomic localization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3,94,97\">",
"     3,94,97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of other tracers (eg, [11C]flumazenil,",
"    <sup>",
"     18",
"    </sup>",
"    fluoroethyl-l-tyrosine, alpha methyl tryptophan, and serotonin agonists) is under investigation and holds promise for improving the sensitivity and specificity of PET for presurgical localization [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/80,85,87,94,98-106\">",
"     80,85,87,94,98-106",
"    </a>",
"    ]. Similarly, coregistration of FDG-PET and MRI show potential for improved sensitivity and specificity compared with either technology alone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/107-109\">",
"     107-109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a single photon emission computed tomography (SPECT) study, a radiolabeled tracer, eg, 99mTc-hexamethyl-propyleneamineoxime (99mTc-HMPAO), is injected and binds on first-pass through the brain. Thus, a SPECT study provides a snapshot of cerebral circulation at the time of injection. The tracer is stable for several hours, allowing delayed imaging of blood flow at the time of injection.",
"   </p>",
"   <p>",
"    In patients with focal epilepsy, ictal SPECT studies typically show hyperperfusion at the seizure focus with surrounding hypoperfusion; postictal and interictal SPECT shows regional hypoperfusion (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59935 \" href=\"UTD.htm?35/24/36224\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/110\">",
"     110",
"    </a>",
"    ]. The sensitivity of SPECT is improved by comparison of ictal and interictal SPECT studies with quantitative subtraction techniques or by statistical comparison with a control database (statistical parametric mapping) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/97,111\">",
"     97,111",
"    </a>",
"    ]. Coregistration with MRI, a technique known as subtraction ictal SPECT scan coregistered with MRI (SISCOM) improves localization and can help predict surgical success [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/111-116\">",
"     111-116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SPECT can be useful in the identification of a possible epileptic focus, particularly when MRI is unremarkable, to identify a potential localization for the seizure focus that can be further tested with intracranial EEG studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. In some cases, re-evaluation of MRI prompted by abnormal SPECT has revealed a subtle structural lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/119\">",
"     119",
"    </a>",
"    ]. Ictal SPECT studies have a high yield in the evaluation of temporal lobe epilepsy that exceeds 90 percent; but the sensitivity for extratemporal seizure foci is lower [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/3,84,120-122\">",
"     3,84,120-122",
"    </a>",
"    ]. In one study of 53 patients with secondary generalized seizures, ictal SPECT identified an unambiguous seizure focus in only 50 percent; however when a single unambiguous region of cerebral blood flow increase was seen, this was the correct localization in 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, SPECT studies have certain limitations in their utility to localize the seizure focus. Injection timing is critical; the tracer takes 30 seconds to reach the brain and the switch from ictal hyperperfusion to hypoperfusion can take place in less than one to two minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/87,97,123\">",
"     87,97,123",
"    </a>",
"    ]. Propagation of seizure activity from the original focus of seizure onset to other brain regions can be even quicker [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/124\">",
"     124",
"    </a>",
"    ]. As a result, areas of ictal hyperperfusion on SPECT may represent a false localization demonstrating areas of seizure propagation rather than seizure onset [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/118,120\">",
"     118,120",
"    </a>",
"    ]. This may make SPECT localization a less reliable predictor of surgical outcome compared to other imaging studies, at least in some case series [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]. One study suggested that an injection time of less than 20 seconds after seizure onset is an important predictor of accurate localization; this can be difficult to achieve [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MAGNETOENCEPHALOGRAPHY AND MAGNETIC SOURCE IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetoencephalography (MEG) is the recording of magnetic fields generated by intraneuronal electrical currents. Magnetic source imaging (MSI) is the combination of MEG source localization with coregistered anatomical imaging (MRI in most cases), in which the magnetic dipole representing an epileptiform discharge is placed on the patient's MRI scan [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/126\">",
"     126",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MEG is similar to EEG. However, while the electrical currents that are measured with EEG are attenuated in strength and spatially blurred by tissues between the brain and the scalp surface, the magnetic fields assessed by MEG are not significantly affected by intervening tissue layers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/127\">",
"     127",
"    </a>",
"    ]. As a result, MEG may allow for more clinically reliable localization of brain activity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MEG and EEG can be viewed as complementary studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/129\">",
"     129",
"    </a>",
"    ]. MEG is maximally sensitive to dipoles situated tangentially to the surface, whereas EEG is maximally sensitive to radial dipoles [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/130\">",
"     130",
"    </a>",
"    ]. Single spikes with small amplitudes (eg, from mesial temporal sources) can be averaged to increase their signal-to-noise ratio. Averaged MEG spikes can thus be helpful in detecting discharges that are hidden in the background noise in simultaneous EEG recordings (",
"    <a class=\"graphic graphic_waveform graphicRef52060 \" href=\"UTD.htm?40/16/41226\">",
"     waveform 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76925 \" href=\"UTD.htm?13/21/13655\">",
"     image 5",
"    </a>",
"    ). This phenomenon is reciprocal: in some cases, EEG spikes are more apparent than on MEG [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/129\">",
"     129",
"    </a>",
"    ]. Some studies suggest that MEG has specific advantages for spike detection in extratemporal epilepsies, particularly those that lie superficially on the brain's surface [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/131-133\">",
"     131-133",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     MEG/MSI",
"    </span>",
"    has been approved for presurgical localization of epilepsy and may be particularly useful for localization of spike sources in the following patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/97,132\">",
"     97,132",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with no lesion visible on MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/132,134-137\">",
"       132,134-137",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Those with cystic lesions (post-traumatic encephalomalacia with prior surgical resection) to determine the relationship between the epileptogenic focus and the lesion;",
"      <span class=\"nowrap\">",
"       MEG/MSI",
"      </span>",
"      also appears to be useful in identifying the extent of the epileptogenic lesion in patients with focal cortical dysplasia, cavernous angiomas, and tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/138-142\">",
"       138-142",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Those with MRI lesions of undetermined significance, including those with dual pathology or multifocal pathology such as tuberous sclerosis and others [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/143-145\">",
"       143-145",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Those who have had previous unsuccessful epilepsy surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/138,146,147\">",
"       138,146,147",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A large study in 455 epilepsy patients demonstrated an average sensitivity for MEG of 70 percent for specific epileptic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/148\">",
"     148",
"    </a>",
"    ]. Among patients who underwent surgical therapy, MSI provided a localization in 89 percent, supplying additional information in 35 percent and information that was crucial to medical decision-making in 10 percent. Similar sensitivity has been reported in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/131,135,149-151\">",
"     131,135,149-151",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MEG is also approved for the localization of neuronal function (similar to evoked potentials and functional MRI) for language, sensorimotor, or visual cortex, and has been used to localize other cortical functions as well. MEG language mapping has been shown to agree with results of the Wada test in 75 to 95 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/49/13082/abstract/129,130,152-154\">",
"     129,130,152-154",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/40/43650?source=see_link\">",
"       \"Patient information: Epilepsy in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/54/38754?source=see_link\">",
"       \"Patient information: Epilepsy in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging is central to the evaluation of patients with epilepsy, especially in the identification of structural brain lesions that can serve as epileptogenic foci, and that might be surgically resectable if the patient becomes refractory to medical treatment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because of its relative insensitivity compared to magnetic resonance imaging, computed tomography (CT) has a limited role in the evaluation of patients with seizures. It is usually restricted to the emergency department setting in the evaluation of potential acute symptomatic seizures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Computed tomography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Virtually all patients with new-onset epilepsy should have a magnetic resonance imaging (MRI) study to identify a potential structural cause of epilepsy including hippocampal sclerosis, brain tumor, dysplasia, vascular malformation, and others. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Specific pathologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While less than half of patients with epilepsy will have a cause identified on MRI, the sensitivity can be substantially improved by utilizing an epilepsy protocol. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Sensitivity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Not all MRI findings are relevant; isolated findings of diffuse atrophy, punctate foci of T2 signal abnormalities in the white matter, and other nonspecific findings are not known to be epileptogenic. MRI findings should be correlated with the patient's seizure semiology and EEG findings; some potentially epileptogenic lesions may be incidental. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Specificity of MRI findings for epilepsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other neuroimaging modalities, positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic source imaging (MSI). are primarily used in the presurgical evaluation of patients with medically refractory epilepsy. These are employed to better define the area of functional defect and epileptogenicity, to identify MRI-occult lesions, and to identify the more active lesion in patients with dual or multiple pathologies. Neuroimaging studies are also used to map neurologic functions as part of surgical planning to predict and limit postoperative neurologic deficits, including sensorimotor, language and memory function.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/1\">",
"      Scheepers B, Clough P, Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure 1998; 7:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/2\">",
"      van Donselaar CA, Stroink H, Arts WF, Dutch Study Group of Epilepsy in Childhood. How confident are we of the diagnosis of epilepsy? Epilepsia 2006; 47 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/3\">",
"      Duncan JS. Imaging and epilepsy. Brain 1997; 120 ( Pt 2):339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/4\">",
"      Recommendations for neuroimaging of patients with epilepsy. Commission on Neuroimaging of the International League Against Epilepsy. Epilepsia 1997; 38:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/5\">",
"      Krumholz A, Wiebe S, Gronseth G, et al. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2007; 69:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/6\">",
"      King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998; 352:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/7\">",
"      Maehara T. Neuroimaging of epilepsy. Neuropathology 2007; 27:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/8\">",
"      Sisodiya SM. Malformations of cortical development: burdens and insights from important causes of human epilepsy. Lancet Neurol 2004; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/9\">",
"      Oster JM, Igbokwe E, Cosgrove GR, Cole AJ. Identifying subtle cortical gyral abnormalities as a predictor of focal cortical dysplasia and a cure for epilepsy. Arch Neurol 2012; 69:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/10\">",
"      Kim YH, Kang HC, Kim DS, et al. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia 2011; 52:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/11\">",
"      Bl&uuml;mcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/12\">",
"      Bernal B, Altman NR. Evidence-based medicine: neuroimaging of seizures. Neuroimaging Clin N Am 2003; 13:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/13\">",
"      Adams SM, Knowles PD. Evaluation of a first seizure. Am Fam Physician 2007; 75:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/14\">",
"      Pohlmann-Eden B, Newton M. First seizure: EEG and neuroimaging following an epileptic seizure. Epilepsia 2008; 49 Suppl 1:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/15\">",
"      Woermann FG, Vollmar C. Clinical MRI in children and adults with focal epilepsy: a critical review. Epilepsy Behav 2009; 15:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/16\">",
"      Von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry 2002; 73:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/17\">",
"      Gaillard WD, Chiron C, Cross JH, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 2009; 50:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/18\">",
"      Vattipally VR, Bronen RA. MR imaging of epilepsy: strategies for successful interpretation. Neuroimaging Clin N Am 2004; 14:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/19\">",
"      Knake S, Triantafyllou C, Wald LL, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology 2005; 65:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/20\">",
"      Phal PM, Usmanov A, Nesbit GM, et al. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy. AJR Am J Roentgenol 2008; 191:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/21\">",
"      Hashiguchi K, Morioka T, Murakami N, et al. Utility of 3-T FLAIR and 3D short tau inversion recovery MR imaging in the preoperative diagnosis of hippocampal sclerosis: direct comparison with 1.5-T FLAIR MR imaging. Epilepsia 2010; 51:1820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/22\">",
"      Rugg-Gunn FJ, Eriksson SH, Symms MR, et al. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 2001; 124:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/23\">",
"      Duning T, Kellinghaus C, Mohammadi S, et al. Individual white matter fractional anisotropy analysis on patients with MRI negative partial epilepsy. J Neurol Neurosurg Psychiatry 2010; 81:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/24\">",
"      Wilke C, van Drongelen W, Kohrman M, He B. Neocortical seizure foci localization by means of a directed transfer function method. Epilepsia 2010; 51:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/25\">",
"      Rugg-Gunn FJ, Eriksson SH, Boulby PA, et al. Magnetization transfer imaging in focal epilepsy. Neurology 2003; 60:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/26\">",
"      Colliot O, Bernasconi N, Khalili N, et al. Individual voxel-based analysis of gray matter in focal cortical dysplasia. Neuroimage 2006; 29:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/27\">",
"      Rugg-Gunn FJ, Boulby PA, Symms MR, et al. Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy. Neurology 2005; 64:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/28\">",
"      Briellmann RS, Jackson GD, Pell GS, et al. Structural abnormalities remote from the seizure focus: a study using T2 relaxometry at 3 T. Neurology 2004; 63:2303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/29\">",
"      de Souza JM, Domingues RC, Cruz LC Jr, et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008; 29:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/30\">",
"      Saini J, Kesavadas C, Thomas B, et al. Susceptibility weighted imaging in the diagnostic evaluation of patients with intractable epilepsy. Epilepsia 2009; 50:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/31\">",
"      Chan S, Chin SS, Nordli DR, et al. Prospective magnetic resonance imaging identification of focal cortical dysplasia, including the non-balloon cell subtype. Ann Neurol 1998; 44:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/32\">",
"      Eriksson SH, Rugg-Gunn FJ, Symms MR, et al. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001; 124:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/33\">",
"      Focke NK, Bonelli SB, Yogarajah M, et al. Automated normalized FLAIR imaging in MRI-negative patients with refractory focal epilepsy. Epilepsia 2009; 50:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/34\">",
"      Edwards JC, Wyllie E, Ruggeri PM, et al. Seizure outcome after surgery for epilepsy due to malformation of cortical development. Neurology 2000; 55:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/35\">",
"      Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002; 125:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/36\">",
"      Cohen-Gadol AA, Ozduman K, Bronen RA, et al. Long-term outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg 2004; 101:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/37\">",
"      Betting LE, Mory SB, Lopes-Cendes I, et al. MRI reveals structural abnormalities in patients with idiopathic generalized epilepsy. Neurology 2006; 67:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/38\">",
"      Gelisse P, Genton P, Raybaud C, et al. Structural brain lesions do not influence the prognosis of juvenile myoclonic epilepsy. Acta Neurol Scand 2000; 102:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/39\">",
"      Gelisse P, Corda D, Raybaud C, et al. Abnormal neuroimaging in patients with benign epilepsy with centrotemporal spikes. Epilepsia 2003; 44:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/40\">",
"      de Timary P, Fouchet P, Sylin M, et al. Non-epileptic seizures: delayed diagnosis in patients presenting with electroencephalographic (EEG) or clinical signs of epileptic seizures. Seizure 2002; 11:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/41\">",
"      Reuber M, Pukrop R, Bauer J, et al. Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol 2003; 53:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/42\">",
"      Lancman ME, Brotherton TA, Asconap&eacute; JJ, Penry JK. Psychogenic seizures in adults: a longitudinal analysis. Seizure 1993; 2:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/43\">",
"      Reuber M, Fern&aacute;ndez G, Helmstaedter C, et al. Evidence of brain abnormality in patients with psychogenic nonepileptic seizures. Epilepsy Behav 2002; 3:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/44\">",
"      Ettinger, AB, Jandorf, L, Cabahug, CJ, et al. Post-ictal SPECT in epileptic vs. non-epileptic seizures. J Epilepsy 1998; 11:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/45\">",
"      Labate A, Gambardella A, Aguglia U, et al. Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology 2010; 74:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/46\">",
"      Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999; 282:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/47\">",
"      Moore KR, Swallow CE, Tsuruda JS. Incidental detection of hippocampal sclerosis on MR images: is it significant? AJNR Am J Neuroradiol 1999; 20:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/48\">",
"      Adcock JE, Wise RG, Oxbury JM, et al. Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage 2003; 18:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/49\">",
"      Li&eacute;geois F, Connelly A, Cross JH, et al. Language reorganization in children with early-onset lesions of the left hemisphere: an fMRI study. Brain 2004; 127:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/50\">",
"      Noppeney U, Price CJ, Duncan JS, Koepp MJ. Reading skills after left anterior temporal lobe resection: an fMRI study. Brain 2005; 128:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/51\">",
"      Sabsevitz DS, Swanson SJ, Hammeke TA, et al. Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery. Neurology 2003; 60:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/52\">",
"      Binder JR, Sabsevitz DS, Swanson SJ, et al. Use of preoperative functional MRI to predict verbal memory decline after temporal lobe epilepsy surgery. Epilepsia 2008; 49:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/53\">",
"      Bonelli SB, Powell R, Yogarajah M, et al. Preoperative amygdala fMRI in temporal lobe epilepsy. Epilepsia 2009; 50:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/54\">",
"      Arora J, Pugh K, Westerveld M, et al. Language lateralization in epilepsy patients: fMRI validated with the Wada procedure. Epilepsia 2009; 50:2225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/55\">",
"      Bonelli SB, Thompson PJ, Yogarajah M, et al. Imaging language networks before and after anterior temporal lobe resection: results of a longitudinal fMRI study. Epilepsia 2012; 53:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/56\">",
"      Benke T, K&ouml;yl&uuml; B, Visani P, et al. Language lateralization in temporal lobe epilepsy: a comparison between fMRI and the Wada Test. Epilepsia 2006; 47:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/57\">",
"      Golby AJ, Poldrack RA, Illes J, et al. Memory lateralization in medial temporal lobe epilepsy assessed by functional MRI. Epilepsia 2002; 43:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/58\">",
"      Rabin ML, Narayan VM, Kimberg DY, et al. Functional MRI predicts post-surgical memory following temporal lobectomy. Brain 2004; 127:2286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/59\">",
"      Richardson MP, Strange BA, Thompson PJ, et al. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain 2004; 127:2419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/60\">",
"      Richardson MP, Strange BA, Duncan JS, Dolan RJ. Memory fMRI in left hippocampal sclerosis: optimizing the approach to predicting postsurgical memory. Neurology 2006; 66:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/61\">",
"      Powell HW, Richardson MP, Symms MR, et al. Preoperative fMRI predicts memory decline following anterior temporal lobe resection. J Neurol Neurosurg Psychiatry 2008; 79:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/62\">",
"      K&ouml;yl&uuml; B, Walser G, Ischebeck A, et al. Functional imaging of semantic memory predicts postoperative episodic memory functions in chronic temporal lobe epilepsy. Brain Res 2008; 1223:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/63\">",
"      Cheung MC, Chan AS, Lam JM, Chan YL. Pre- and postoperative fMRI and clinical memory performance in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2009; 80:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/64\">",
"      Bonelli SB, Powell RH, Yogarajah M, et al. Imaging memory in temporal lobe epilepsy: predicting the effects of temporal lobe resection. Brain 2010; 133:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/65\">",
"      Woermann FG, Jokeit H, Luerding R, et al. Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology 2003; 61:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/66\">",
"      Wellmer J, Weber B, Urbach H, et al. Cerebral lesions can impair fMRI-based language lateralization. Epilepsia 2009; 50:2213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/67\">",
"      Binder JR, Swanson SJ, Sabsevitz DS, et al. A comparison of two fMRI methods for predicting verbal memory decline after left temporal lobectomy: language lateralization versus hippocampal activation asymmetry. Epilepsia 2010; 51:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/68\">",
"      Wagner K, Hader C, Metternich B, et al. Who needs a Wada test? Present clinical indications for amobarbital procedures. J Neurol Neurosurg Psychiatry 2012; 83:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/69\">",
"      Dym RJ, Burns J, Freeman K, Lipton ML. Is functional MR imaging assessment of hemispheric language dominance as good as the Wada test?: a meta-analysis. Radiology 2011; 261:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/70\">",
"      Federico P, Archer JS, Abbott DF, Jackson GD. Cortical/subcortical BOLD changes associated with epileptic discharges: an EEG-fMRI study at 3 T. Neurology 2005; 64:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/71\">",
"      Kobayashi E, Bagshaw AP, Jansen A, et al. Intrinsic epileptogenicity in polymicrogyric cortex suggested by EEG-fMRI BOLD responses. Neurology 2005; 64:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/72\">",
"      Liu Y, Yang T, Yang X, et al. EEG-fMRI study of the interictal epileptic activity in patients with partial epilepsy. J Neurol Sci 2008; 268:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/73\">",
"      Moeller F, Tyvaert L, Nguyen DK, et al. EEG-fMRI: adding to standard evaluations of patients with nonlesional frontal lobe epilepsy. Neurology 2009; 73:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/74\">",
"      Thornton R, Laufs H, Rodionov R, et al. EEG correlated functional MRI and postoperative outcome in focal epilepsy. J Neurol Neurosurg Psychiatry 2010; 81:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/75\">",
"      Archer JS, Abbott DF, Masterton RA, et al. Functional MRI interactions between dysplastic nodules and overlying cortex in periventricular nodular heterotopia. Epilepsy Behav 2010; 19:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/76\">",
"      Gholipour T, Moeller F, Pittau F, et al. Reproducibility of interictal EEG-fMRI results in patients with epilepsy. Epilepsia 2011; 52:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/77\">",
"      Thornton R, Vulliemoz S, Rodionov R, et al. Epileptic networks in focal cortical dysplasia revealed using electroencephalography-functional magnetic resonance imaging. Ann Neurol 2011; 70:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/78\">",
"      Pittau F, Dubeau F, Gotman J. Contribution of EEG/fMRI to the definition of the epileptic focus. Neurology 2012; 78:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/79\">",
"      Valk PE, Laxer KD, Barbaro NM, et al. High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology 1993; 186:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/80\">",
"      Ryvlin P, Bouvard S, Le Bars D, et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998; 121 ( Pt 11):2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/81\">",
"      Gaillard WD, Bhatia S, Bookheimer SY, et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995; 45:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/82\">",
"      Ryvlin P, Philippon B, Cinotti L, et al. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT. Ann Neurol 1992; 31:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/83\">",
"      Swartz BE, Tomiyasu U, Delgado-Escueta AV, et al. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome. Epilepsia 1992; 33:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/84\">",
"      Salanova V, Markand O, Worth R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol Scand 2004; 109:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/85\">",
"      la Foug&egrave;re C, Rominger A, F&ouml;rster S, et al. PET and SPECT in epilepsy: a critical review. Epilepsy Behav 2009; 15:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/86\">",
"      Henry TR, Engel J Jr, Mazziotta JC. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy. J Nucl Med 1993; 34:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/87\">",
"      Van Paesschen W, Dupont P, Sunaert S, et al. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol 2007; 20:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/88\">",
"      Lee SK, Lee SY, Kim KK, et al. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 2005; 58:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/89\">",
"      Willmann O, Wennberg R, May T, et al. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure 2007; 16:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/90\">",
"      Carne RP, O'Brien TJ, Kilpatrick CJ, et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain 2004; 127:2276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/91\">",
"      LoPinto-Khoury C, Sperling MR, Skidmore C, et al. Surgical outcome in PET-positive, MRI-negative patients with temporal lobe epilepsy. Epilepsia 2012; 53:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/92\">",
"      Muzik O, da Silva EA, Juhasz C, et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000; 54:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/93\">",
"      Lee N, Radtke RA, Gray L, et al. Neuronal migration disorders: positron emission tomography correlations. Ann Neurol 1994; 35:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/94\">",
"      Juh&aacute;sz C, Chugani DC, Muzik O, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001; 56:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/95\">",
"      Kim SK, Lee DS, Lee SK, et al. Diagnostic performance of [18F]FDG-PET and ictal [99mTc]-HMPAO SPECT in occipital lobe epilepsy. Epilepsia 2001; 42:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/96\">",
"      Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009; 50:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/97\">",
"      Knowlton RC. The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation. Epilepsy Behav 2006; 8:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/98\">",
"      Kaneko K, Sasaki M, Morioka T, et al. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET. Nucl Med Commun 2006; 27:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/99\">",
"      Umeoka S, Matsuda K, Baba K, et al. Usefulness of 123I-iomazenil single-photon emission computed tomography in discriminating between mesial and lateral temporal lobe epilepsy in patients in whom magnetic resonance imaging demonstrates normal findings. J Neurosurg 2007; 107:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/100\">",
"      Fedi M, Reutens D, Okazawa H, et al. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 2001; 57:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/101\">",
"      Juh&aacute;sz C, Chugani HT. Imaging the epileptic brain with positron emission tomography. Neuroimaging Clin N Am 2003; 13:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/102\">",
"      Kumar JS, Mann JJ. PET tracers for 5-HT(1A) receptors and uses thereof. Drug Discov Today 2007; 12:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/103\">",
"      Didelot A, Ryvlin P, Lothe A, et al. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 2008; 131:2751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/104\">",
"      Liew CJ, Lim YM, Bonwetsch R, et al. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy. Epilepsia 2009; 50:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/105\">",
"      Juh&aacute;sz C, Asano E, Shah A, et al. Focal decreases of cortical GABAA receptor binding remote from the primary seizure focus: what do they indicate? Epilepsia 2009; 50:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/106\">",
"      Kasper BS, Struffert T, Kasper EM, et al. 18Fluoroethyl-L-tyrosine-PET in long-term epilepsy associated glioneuronal tumors. Epilepsia 2011; 52:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/107\">",
"      Salamon N, Kung J, Shaw SJ, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology 2008; 71:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/108\">",
"      Chassoux F, Rodrigo S, Semah F, et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 2010; 75:2168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/109\">",
"      Rub&iacute; S, Setoain X, Donaire A, et al. Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia 2011; 52:2216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/110\">",
"      Rowe CC, Berkovic SF, Sia ST, et al. Localization of epileptic foci with postictal single photon emission computed tomography. Ann Neurol 1989; 26:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/111\">",
"      Kazemi NJ, Worrell GA, Stead SM, et al. Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology 2010; 74:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/112\">",
"      O'Brien TJ, So EL, Cascino GD, et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia 2004; 45:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/113\">",
"      O'Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 1998; 50:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/114\">",
"      O'Brien TJ, So EL, Mullan BP, et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology 1999; 52:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/115\">",
"      von Oertzen TJ, Mormann F, Urbach H, et al. Prospective use of subtraction ictal SPECT coregistered to MRI (SISCOM) in presurgical evaluation of epilepsy. Epilepsia 2011; 52:2239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/116\">",
"      Lee JY, Joo EY, Park HS, et al. Repeated ictal SPECT in partial epilepsy patients: SISCOM analysis. Epilepsia 2011; 52:2249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/117\">",
"      Cascino GD, Buchhalter JR, Mullan BP, So EL. Ictal SPECT in nonlesional extratemporal epilepsy. Epilepsia 2004; 45 Suppl 4:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/118\">",
"      Varghese GI, Purcaro MJ, Motelow JE, et al. Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures. Brain 2009; 132:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/119\">",
"      Dupont P, Van Paesschen W, Palmini A, et al. Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia 2006; 47:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/120\">",
"      Lewis PJ, Siegel A, Siegel AM, et al. Does performing image registration and subtraction in ictal brain SPECT help localize neocortical seizures? J Nucl Med 2000; 41:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/121\">",
"      Newton MR, Berkovic SF, Austin MC, et al. SPECT in the localisation of extratemporal and temporal seizure foci. J Neurol Neurosurg Psychiatry 1995; 59:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/122\">",
"      Devous MD Sr, Thisted RA, Morgan GF, et al. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 1998; 39:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/123\">",
"      Van Paesschen W. Ictal SPECT. Epilepsia 2004; 45 Suppl 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/124\">",
"      Van Paesschen W, Dupont P, Van Driel G, et al. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain 2003; 126:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/125\">",
"      Lee SK, Lee SY, Yun CH, et al. Ictal SPECT in neocortical epilepsies: clinical usefulness and factors affecting the pattern of hyperperfusion. Neuroradiology 2006; 48:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/126\">",
"      Gallen CC, Hirschkoff EC, Buchanan DS. Magnetoencephalography and magnetic source imaging. Capabilities and limitations. Neuroimaging Clin N Am 1995; 5:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/127\">",
"      Ricci GB, Romani GL, Salustri C, et al. Study of focal epilepsy by multichannel neuromagnetic measurements. Electroencephalogr Clin Neurophysiol 1987; 66:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/128\">",
"      Ebersole JS. Magnetoencephalography/magnetic source imaging in the assessment of patients with epilepsy. Epilepsia 1997; 38 Suppl 4:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/129\">",
"      Baumgartner C, Pataraia E. Revisiting the role of magnetoencephalography in epilepsy. Curr Opin Neurol 2006; 19:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/130\">",
"      Knowlton RC, Shih J. Magnetoencephalography in epilepsy. Epilepsia 2004; 45 Suppl 4:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/131\">",
"      Knowlton RC, Laxer KD, Aminoff MJ, et al. Magnetoencephalography in partial epilepsy: clinical yield and localization accuracy. Ann Neurol 1997; 42:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/132\">",
"      Shiraishi H, Watanabe Y, Watanabe M, et al. Interictal and ictal magnetoencephalographic study in patients with medial frontal lobe epilepsy. Epilepsia 2001; 42:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/133\">",
"      de Jongh A, de Munck JC, Gon&ccedil;alves SI, Ossenblok P. Differences in MEG/EEG epileptic spike yields explained by regional differences in signal-to-noise ratios. J Clin Neurophysiol 2005; 22:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/134\">",
"      RamachandranNair R, Otsubo H, Shroff MM, et al. MEG predicts outcome following surgery for intractable epilepsy in children with normal or nonfocal MRI findings. Epilepsia 2007; 48:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/135\">",
"      Knowlton RC, Razdan SN, Limdi N, et al. Effect of epilepsy magnetic source imaging on intracranial electrode placement. Ann Neurol 2009; 65:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/136\">",
"      Seo JH, Holland K, Rose D, et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology 2011; 76:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/137\">",
"      De Ti&egrave;ge X, Carrette E, Legros B, et al. Clinical added value of magnetic source imaging in the presurgical evaluation of refractory focal epilepsy. J Neurol Neurosurg Psychiatry 2012; 83:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/138\">",
"      Amo C, Salda&ntilde;a C, Hidalgo MG, et al. Magnetoencephalographic localization of peritumoral temporal epileptic focus previous surgical resection. Seizure 2003; 12:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/139\">",
"      Otsubo H, Ochi A, Elliott I, et al. MEG predicts epileptic zone in lesional extrahippocampal epilepsy: 12 pediatric surgery cases. Epilepsia 2001; 42:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/140\">",
"      Stefan H, Hammen T. Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 2004; 110:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/141\">",
"      Widjaja E, Zarei Mahmoodabadi S, Otsubo H, et al. Subcortical alterations in tissue microstructure adjacent to focal cortical dysplasia: detection at diffusion-tensor MR imaging by using magnetoencephalographic dipole cluster localization. Radiology 2009; 251:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/142\">",
"      Stefan H, Wu X, Buchfelder M, et al. MEG in frontal lobe epilepsies: localization and postoperative outcome. Epilepsia 2011; 52:2233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/143\">",
"      Iida K, Otsubo H, Mohamed IS, et al. Characterizing magnetoencephalographic spike sources in children with tuberous sclerosis complex. Epilepsia 2005; 46:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/144\">",
"      Stefan H, Nimsky C, Scheler G, et al. Periventricular nodular heterotopia: A challenge for epilepsy surgery. Seizure 2007; 16:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/145\">",
"      Stefan H, Hummel C, Hopfeng&auml;rtner R, et al. Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol 2000; 17:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/146\">",
"      Mohamed IS, Otsubo H, Ochi A, et al. Utility of magnetoencephalography in the evaluation of recurrent seizures after epilepsy surgery. Epilepsia 2007; 48:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/147\">",
"      Kirchberger K, Hummel C, Stefan H. Postoperative multichannel magnetoencephalography in patients with recurrent seizures after epilepsy surgery. Acta Neurol Scand 1998; 98:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/148\">",
"      Stefan H, Hummel C, Scheler G, et al. Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain 2003; 126:2396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/149\">",
"      Pataraia E, Simos PG, Castillo EM, et al. Does magnetoencephalography add to scalp video-EEG as a diagnostic tool in epilepsy surgery? Neurology 2004; 62:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/150\">",
"      Knowlton RC, Elgavish RA, Limdi N, et al. Functional imaging: I. Relative predictive value of intracranial electroencephalography. Ann Neurol 2008; 64:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/151\">",
"      Knowlton RC, Elgavish RA, Bartolucci A, et al. Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol 2008; 64:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/152\">",
"      Doss RC, Zhang W, Risse GL, Dickens DL. Lateralizing language with magnetic source imaging: validation based on the Wada test. Epilepsia 2009; 50:2242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/153\">",
"      McDonald CR, Thesen T, Hagler DJ Jr, et al. Distributed source modeling of language with magnetoencephalography: application to patients with intractable epilepsy. Epilepsia 2009; 50:2256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/49/13082/abstract/154\">",
"      Findlay AM, Ambrose JB, Cahn-Weiner DA, et al. Dynamics of hemispheric dominance for language assessed by magnetoencephalographic imaging. Ann Neurol 2012; 71:668.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2228 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.244-E0F60D9195-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13082=[""].join("\n");
var outline_f12_49_13082=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPUTED TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MAGNETIC RESONANCE IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Specific pathologies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Sensitivity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Epilepsy protocol for MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4070890\">",
"      Advanced MRI techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Specificity of MRI findings for epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FUNCTIONAL MAGNETIC RESONANCE IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POSITRON EMISSION TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MAGNETOENCEPHALOGRAPHY AND MAGNETIC SOURCE IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/2228\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2228|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/2/6179\" title=\"diagnostic image 1A\">",
"      MRI MTS T2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/58/8097\" title=\"diagnostic image 1B\">",
"      MRI MTS FLAIR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/43/15027\" title=\"diagnostic image 2\">",
"      MRI Focal cortical dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/28/453\" title=\"diagnostic image 3\">",
"      Interictal PET scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/24/36224\" title=\"diagnostic image 4\">",
"      Ictal SPECT scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/21/13655\" title=\"diagnostic image 5\">",
"      Magnetic source imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2228|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/46/43755\" title=\"table 1\">",
"      Cortical dysgenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2228|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?40/16/41226\" title=\"waveform 1\">",
"      MEG - magnetoencephalography recording",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=related_link\">",
"      Benign partial epilepsies of childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=related_link\">",
"      Clinical and laboratory diagnosis of seizures in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=related_link\">",
"      Clinical manifestations and diagnosis of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=related_link\">",
"      Electroencephalography (EEG) in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15413?source=related_link\">",
"      Epidemiology, transmission and prevention of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=related_link\">",
"      Epilepsy syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=related_link\">",
"      Febrile seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=related_link\">",
"      Localization-related (partial) epilepsy: Causes and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22871?source=related_link\">",
"      Magnetic resonance imaging changes related to acute seizure activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/40/43650?source=related_link\">",
"      Patient information: Epilepsy in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/54/38754?source=related_link\">",
"      Patient information: Epilepsy in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40841?source=related_link\">",
"      Seizures and epilepsy in the elderly patient: Etiology, clinical presentation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41593?source=related_link\">",
"      Surgical therapy of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15368?source=related_link\">",
"      Video and ambulatory EEG monitoring in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_49_13083="Management infertility";
var content_f12_49_13083=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    General principles of management of infertile couples",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Involve both partners in the evaluation and management of infertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Recommend lifestyle modifications to enhance fertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Couple - smoking cessation and reduce exposure to potential environmental toxins",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Women - abstinence from alcohol, reduction of excessive caffeine intake, weight modulation to achieve target body mass index (20-25 kg/m2)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Perform infertility evaluation according to established guidelines",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Identify causes of infertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Reversible causes - implement medical or surgical therapy to correct the etiology of infertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Irreversible causes - utilize assisted reproductive technologies, gamete donation, gestational carrier, adoption to overcome the etiology of infertility",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13083=[""].join("\n");
var outline_f12_49_13083=null;
var title_f12_49_13084="Electrical cardioversion AF";
var content_f12_49_13084=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA/ESC guideline summary: Direct-current (DC) cardioversion of atrial fibrillation (AF) and flutter (AFl)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that immediate R-wave synchronized DC cardioversion of AF or AFl is indicated in the following settings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; AF with a rapid ventricular response that does not respond promptly to pharmacologic measures and there is evidence of ongoing myocardial ischemia, symptomatic hypotension, angina, or heart failure.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Pre-excitation in the presence of very rapid tachycardia or hemodynamic instability.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Unacceptable symptoms in the absence of hemodynamic instability. Repeated direct current cardioversion attempts may be made following administration of antiarrhythmic drugs for early relapse. In this category, immediate cardioversion may not be necessary.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or opinion is in favor of the usefulness of DC cardioversion of AF or AFl for patients in the following settings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Part of a long-term management strategy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; If the patient prefers, management of symptomatic or recurrent AF if used infrequently.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence and/or general agreement that DC cardioversion of AF or AFl is not useful or may be harmful to patients in the following settings and should therefore be avoided",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Frequent repetition of direct current cardioversion for repeated relapses of AF after short periods of sinus rhythm in patients who have received procedures despite prophylactic antiarrhythmic drug treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Digitalis toxicity or hypokalemia, settings in which DC cardioversion is contraindicated.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 2006; 48:e149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13084=[""].join("\n");
var outline_f12_49_13084=null;
var title_f12_49_13085="Rx of ectopic ACTH secretion";
var content_f12_49_13085=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Treatment of ectopic ACTH syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 202px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13085=[""].join("\n");
var outline_f12_49_13085=null;
var title_f12_49_13086="Risk factors for acquiring HAV";
var content_f12_49_13086=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 487px\">",
"   <div class=\"ttl\">",
"    Risk factors for acquiring hepatitis A",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 467px; height: 278px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Risk factors for acquiring hepatitis A in the United States from 1983 to 1991. Most cases are acquired through personal contact with an infected person.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Centers for Disease Control and Prevention, Viral Hepatitis Surveillance Program.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13086=[""].join("\n");
var outline_f12_49_13086=null;
var title_f12_49_13087="Clock locating lesion";
var content_f12_49_13087=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clock position in locating a lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The location can also be indicated as a clock position. Each breast is divided into clock positions with the nipple as the center.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_49_13087=[""].join("\n");
var outline_f12_49_13087=null;
